Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,21343,105,2.40 [0.81-7.14],0.1138942307753252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,20726,100,1.39 [0.98-1.96],0.0648522870025877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,24459,123,1.45 [1.11-1.90],0.0066229940893115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,20651,100,1.04 [0.61-1.78],0.8791626479199683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,24334,122,1.13 [0.86-1.49],0.3819114191031856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,24459,123,1.13 [0.90-1.41],0.2944980721680246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,21324,106,1.06 [0.94-1.21],0.3542407618451338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,20651,100,1.10 [0.83-1.46],0.5017676381156913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23987,116,1.09 [0.90-1.32],0.3958839243018004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",20915,101,0.93 [0.69-1.25],0.6149355879365961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",21317,104,1.00 [0.81-1.24],0.9721647325431488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,24361,122,1.26 [0.71-2.22],0.4262311713579947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,21324,106,0.73 [0.36-1.49],0.3866350602810363
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,24142,117,1.17 [0.87-1.58],0.3083103943281839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,20839,104,0.72 [0.40-1.29],0.2639833288624824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,21226,105,1.05 [0.90-1.24],0.5194788453288688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,24589,123,1.01 [0.73-1.39],0.9555303867838986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,20704,98,0.86 [0.55-1.34],0.4984089192783236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,24657,120,1.07 [0.66-1.75],0.7752981433066084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,24763,121,1.18 [0.91-1.53],0.2151431646938369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,21201,104,1.16 [0.72-1.86],0.534365511686341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,20704,98,0.85 [0.65-1.12],0.2483171835135542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,20651,100,1.20 [0.74-1.94],0.4645841124166145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",24142,117,1.57 [1.20-2.04],0.0009170199693596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,20651,100,1.15 [0.85-1.54],0.3690393607967099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,24128,118,1.23 [0.79-1.93],0.3610354803793951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,24380,122,4.23 [2.39-7.49],7.258854639405063e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,24589,123,1.11 [0.87-1.43],0.3973630071149132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,20651,100,1.09 [0.78-1.53],0.5960248870052554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,20759,103,1.25 [0.95-1.65],0.1137544058748703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,24879,125,1.60 [1.08-2.37],0.0186972018018907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,24396,119,2.13 [1.49-3.03],2.924580908287077e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20704,98,1.70 [1.25-2.32],0.0007850106781548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,24142,117,2.87 [1.71-4.82],6.334914901477336e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,24421,122,1.36 [0.86-2.14],0.1890965007659346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,24879,125,1.09 [0.69-1.72],0.7203269317593799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,24773,121,3.57 [2.43-5.23],7.866554401932622e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,21226,105,1.86 [1.07-3.23],0.0288236544159972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,20704,98,1.19 [0.67-2.09],0.5571762702007277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,24871,123,0.83 [0.42-1.65],0.6020793800488236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,24459,123,1.16 [0.79-1.70],0.4404170151858789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,24142,117,1.33 [0.92-1.90],0.1256863722202582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,20704,98,0.86 [0.50-1.48],0.5817197687748201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,24624,121,0.78 [0.55-1.09],0.1469626937866054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,21308,103,1.14 [0.65-2.01],0.6526265735370524
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,20726,100,1.66 [0.80-3.46],0.1774233794164043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,21317,104,0.89 [0.56-1.44],0.646410719991269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,23987,116,1.06 [0.67-1.66],0.8015574070238944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,20839,104,0.96 [0.74-1.26],0.7928628635707331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,24380,122,1.21 [0.75-1.96],0.4320252403461306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,20839,104,0.45 [0.28-0.75],0.001922036187519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,21226,105,2.31 [1.72-3.09],2.060451916124748e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,24670,121,2.99 [1.77-5.05],4.316218568437162e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,24733,122,2.90 [1.86-4.52],2.571913963786694e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,21317,104,1.15 [0.60-2.20],0.6788240291293295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,24459,123,1.27 [1.02-1.58],0.0291054453776276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,24589,123,1.10 [0.61-1.98],0.7505097807746302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,20657,98,1.09 [0.85-1.40],0.5028250166132082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,20839,104,0.88 [0.69-1.13],0.324532518908009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,24142,117,1.16 [0.97-1.40],0.1111514325500097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,21343,105,1.26 [0.96-1.67],0.098300073724353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,24795,121,1.43 [0.77-2.63],0.2574671755361439
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,20651,100,1.10 [0.86-1.39],0.4561407027457612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,20839,104,1.10 [0.89-1.36],0.3739239735999259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFM,Afamin,21343,105,0.58 [0.22-1.49],0.2546531595784546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,24344,122,1.14 [0.90-1.44],0.2923641716073023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,20657,98,1.10 [0.88-1.37],0.4078750555642554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,24503,120,1.36 [0.92-2.02],0.127547194629743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,23801,120,1.12 [0.95-1.31],0.1769503610863132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,23956,116,0.80 [0.60-1.07],0.1350528503457655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,24670,121,2.01 [1.31-3.10],0.0014120350597948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,24879,125,0.93 [0.70-1.25],0.6459452311023989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,21324,106,0.54 [0.21-1.39],0.2019595792005115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,24589,123,1.10 [0.91-1.34],0.3213512853264622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,24589,123,1.14 [0.91-1.43],0.2612620156147606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,20726,100,2.07 [1.31-3.25],0.0016674518742412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,20726,100,1.57 [0.87-2.83],0.1308184084144339
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,21201,104,1.05 [0.80-1.37],0.7160677511118545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,21324,106,1.41 [0.71-2.78],0.322506861576702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,24527,119,1.01 [0.84-1.22],0.9091346855858912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",20725,96,1.14 [0.94-1.39],0.1851463428287337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,23987,116,1.36 [1.01-1.83],0.0462441526419687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,20726,100,0.96 [0.67-1.35],0.7974646572164538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",24415,123,1.06 [0.92-1.23],0.4124626806099454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,24589,123,1.02 [0.79-1.30],0.9006635647743724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",21260,104,1.08 [0.91-1.29],0.3746461459155377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,20839,104,1.88 [1.03-3.45],0.0400986923365246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,23987,116,1.01 [0.81-1.25],0.927884355018981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,20725,96,1.12 [0.83-1.50],0.4519713743405186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,24142,117,0.93 [0.67-1.29],0.6481264177998305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,20704,98,1.09 [0.84-1.42],0.4955282454992039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,23999,120,1.13 [0.89-1.44],0.3147995665765418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,21284,104,1.03 [0.89-1.19],0.7270731201438129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,23860,116,0.96 [0.72-1.27],0.7677755316067415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,24871,123,2.55 [1.16-5.60],0.0195148738949245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,24565,119,1.00 [0.74-1.34],0.9920186984141662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",21201,104,0.93 [0.63-1.38],0.7186462322403165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",24539,123,1.20 [0.98-1.49],0.0825394054237005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",21284,104,1.28 [0.90-1.83],0.174281831689433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,20915,101,1.00 [0.65-1.53],0.9958672271847784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,20704,98,0.84 [0.71-1.00],0.0443798588291236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",24459,123,1.12 [0.97-1.29],0.123881385656356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,24128,118,1.25 [0.76-2.05],0.3784067426934422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,24764,121,2.35 [1.03-5.34],0.0420404977683952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,21308,103,1.96 [0.96-3.97],0.0627850740462563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,23999,120,1.23 [1.00-1.53],0.0544002705542934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,20725,96,1.19 [0.86-1.65],0.2917853150599322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,24459,123,1.13 [0.56-2.26],0.7403981940057067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,24128,118,1.05 [0.74-1.47],0.7986881597623088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,20839,104,1.06 [0.67-1.69],0.7982737703515856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,21134,104,1.47 [1.11-1.96],0.0073827206381162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,21260,104,1.20 [0.93-1.55],0.1513819411880485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19988,102,1.15 [0.81-1.64],0.4276489087855091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,23661,118,1.03 [0.73-1.46],0.8634739699522617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,22919,114,1.07 [0.75-1.51],0.7216947887821884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,24471,119,1.18 [0.74-1.86],0.4903545784605005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,24491,119,0.85 [0.71-1.03],0.0928622042179925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,24795,121,1.65 [1.11-2.46],0.0138172202817006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,24227,121,1.33 [0.77-2.30],0.3052446747767343
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,24588,120,1.16 [0.77-1.73],0.475708875575107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,24561,120,1.52 [0.96-2.40],0.0756757252020645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,24635,121,1.22 [0.86-1.74],0.2600580847400379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,24795,121,0.91 [0.59-1.40],0.6750400574653539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,20651,100,0.94 [0.70-1.25],0.6757195636584221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,20704,98,1.06 [0.83-1.35],0.6472949973794466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,20560,100,0.88 [0.62-1.27],0.5009656652342565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,23987,116,1.12 [0.86-1.46],0.409140973143494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,20726,100,1.03 [0.65-1.65],0.8856716688372498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,24587,120,0.78 [0.43-1.41],0.4128948822685809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,20710,104,1.26 [0.89-1.78],0.1887130299067853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,23999,120,1.06 [0.87-1.30],0.548392470588302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,24525,123,0.95 [0.75-1.20],0.6447954031646523
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,20429,99,1.33 [1.06-1.66],0.0135470638958355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,24773,121,0.99 [0.79-1.24],0.9061835899203056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,24465,123,0.99 [0.80-1.23],0.9455698498723238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,23926,120,1.34 [0.80-2.23],0.2641472100637836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],24128,118,0.95 [0.70-1.29],0.7414528088303994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,24632,120,0.74 [0.44-1.25],0.2629938406836746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,21201,104,1.19 [0.95-1.49],0.1213189066788888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,20725,96,1.55 [1.15-2.09],0.0035584164007235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,21226,105,1.18 [0.94-1.50],0.1578301591321408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,21260,104,1.32 [0.92-1.90],0.1306082476585068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24459,123,1.53 [1.18-1.97],0.0011084299052048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,21163,102,1.50 [0.86-2.62],0.1553406670680751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,24730,121,1.22 [0.94-1.57],0.1273218782630626
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,24589,123,0.94 [0.69-1.28],0.675528319453728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,21343,105,0.83 [0.40-1.71],0.6155955207203698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,21324,106,1.11 [0.76-1.62],0.5948874151862261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,21343,105,1.23 [0.76-1.98],0.3985156417828461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,21324,106,0.89 [0.40-1.99],0.7753149115948703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,20726,100,0.89 [0.57-1.38],0.6046996619359251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,21298,102,0.91 [0.55-1.52],0.7221264182634144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,20335,94,0.76 [0.44-1.33],0.339082039535611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,21343,105,1.12 [0.91-1.39],0.2778131730535886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,21324,106,1.57 [0.78-3.17],0.2050987792014037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,24565,119,0.76 [0.48-1.21],0.2465395208374907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,21324,106,1.05 [0.79-1.40],0.7248834428575769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,24603,120,0.53 [0.30-0.94],0.0296434458720471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,24523,119,0.91 [0.71-1.16],0.4506240274021791
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,20839,104,0.96 [0.82-1.14],0.6572716195856726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,24394,122,1.34 [0.95-1.89],0.0981971994845351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,20915,101,1.20 [0.93-1.55],0.1553739149493219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,24459,123,1.29 [0.92-1.81],0.1361942603200293
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,21226,105,0.97 [0.81-1.15],0.6957605334575861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,21284,104,1.06 [0.81-1.38],0.6865383100684568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,24460,121,1.35 [1.00-1.82],0.0473269411927167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",21201,104,1.37 [0.97-1.93],0.0769205883879435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,23987,116,1.12 [0.79-1.59],0.5340192808253789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,23987,116,1.19 [0.92-1.52],0.1852715048710865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,20915,101,1.45 [1.01-2.09],0.0438958217828526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,20839,104,1.08 [0.86-1.35],0.5204071262529797
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,20560,100,1.17 [0.93-1.47],0.18036091657332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,21260,104,1.09 [0.89-1.35],0.393814453836251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,21284,104,1.23 [1.02-1.49],0.0345197899523988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,24568,123,1.04 [0.89-1.21],0.6067051035911417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,20657,98,1.27 [1.03-1.58],0.0283133935156526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,20657,98,1.01 [0.63-1.64],0.9543954992615956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,23999,120,1.18 [0.85-1.65],0.3146130514064323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,20651,100,1.04 [0.79-1.36],0.7765407938929942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,20651,100,1.12 [0.71-1.78],0.6302707434541281
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,20657,98,1.12 [0.84-1.48],0.4468154347653496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,24128,118,1.31 [0.92-1.87],0.1376062531361239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,20651,100,0.97 [0.66-1.43],0.8696059175821904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,24565,119,1.11 [0.78-1.58],0.5543169274856543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,24459,123,1.32 [1.00-1.73],0.0472626696923116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,24632,120,1.49 [0.93-2.39],0.0988295917477929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,20657,98,1.03 [0.76-1.39],0.8594841499843866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,24128,118,1.12 [0.82-1.52],0.4827723416337459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,21130,102,1.35 [0.96-1.90],0.0834050811831392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,24421,122,1.15 [0.84-1.57],0.3922049919537901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,24421,122,2.24 [1.39-3.62],0.0008897491548112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,21324,106,2.22 [1.11-4.43],0.0234476428393503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,21317,104,0.60 [0.29-1.24],0.1685709807983279
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,21284,104,1.24 [0.95-1.63],0.1188638944127627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,20726,100,1.08 [0.89-1.30],0.4404871991454095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,20651,100,0.89 [0.70-1.14],0.3623069617578415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,23999,120,1.11 [0.91-1.36],0.2944506713578382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,20560,100,0.91 [0.50-1.65],0.748887525187867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,21226,105,1.13 [0.91-1.40],0.2548769075948782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,23987,116,1.05 [0.80-1.37],0.7425980018668019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,24624,121,1.22 [0.97-1.52],0.0851872791817653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,20651,100,1.04 [0.71-1.51],0.8420023468312934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,20651,100,1.33 [0.75-2.34],0.3270644832940292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,20651,100,0.87 [0.52-1.46],0.5934032244979228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,20560,100,1.06 [0.67-1.66],0.8095048622000242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,20651,100,1.20 [0.94-1.53],0.1456410959896815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",20651,100,1.14 [0.83-1.57],0.4067836854746959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",24670,121,0.97 [0.84-1.12],0.6654145073640643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",23999,120,1.08 [0.75-1.56],0.682630613423391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,23987,116,1.33 [0.97-1.83],0.0754199186189355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,24459,123,1.02 [0.55-1.87],0.9552918449751095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,23952,120,1.16 [0.92-1.46],0.1981197121494672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,20726,100,1.29 [1.01-1.66],0.0436852905984921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,20651,100,1.10 [0.91-1.32],0.3225792826995948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,21226,105,1.55 [1.18-2.05],0.0016641536252241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",21343,105,0.62 [0.20-1.88],0.3968414267771515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,23999,120,1.18 [0.94-1.48],0.1441048405859707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,20657,98,1.05 [0.89-1.24],0.5737739606480631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,21284,104,1.37 [1.00-1.87],0.0510655871601286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,21260,104,1.16 [0.87-1.56],0.3112010763247874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,24568,123,1.05 [0.89-1.24],0.5522398760741496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,24632,120,1.77 [1.01-3.12],0.0473292525272296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,21284,104,1.31 [0.96-1.78],0.0872024160920055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,23822,116,1.16 [0.96-1.40],0.1212728238830577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,21343,105,1.60 [1.30-1.97],8.770000853698728e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,20651,100,0.64 [0.24-1.72],0.3811224584599185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",20726,100,1.27 [0.76-2.15],0.364000515510094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",24670,121,2.94 [1.71-5.06],9.69462462965782e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",24565,119,1.09 [0.57-2.12],0.7887944498201593
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,20704,98,1.55 [0.89-2.70],0.1180175021123849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,24568,123,1.16 [0.94-1.44],0.1544109329413133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,24380,122,1.30 [0.86-1.96],0.2164187179068638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,20704,98,1.63 [1.20-2.21],0.0015762356774732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,24142,117,1.77 [1.16-2.70],0.0078146288211884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23987,116,1.42 [1.12-1.78],0.0031027827250066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,23987,116,2.42 [1.64-3.57],9.033170843264243e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,24568,123,1.07 [0.92-1.24],0.401886590923057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,21260,104,1.34 [1.12-1.61],0.0017624574538233
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,20725,96,1.10 [0.90-1.34],0.3684002493582116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,23962,120,1.14 [0.95-1.35],0.1493566571729264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,24565,119,1.83 [0.95-3.53],0.0725144480006903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,24421,122,1.13 [0.70-1.81],0.6153189547729727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",21317,104,1.55 [0.92-2.61],0.1024077030754715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",20657,98,1.11 [0.80-1.55],0.5273991601503296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,20923,103,0.78 [0.40-1.53],0.4721583162017733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,21226,105,1.98 [1.68-2.32],1.870100782821239e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,21260,104,1.01 [0.84-1.22],0.91097690166008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",24568,123,1.07 [0.74-1.54],0.7346402337146266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,20704,98,1.47 [1.16-1.86],0.0011969550547068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,20560,100,1.20 [0.94-1.53],0.1367745700769727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,21201,104,1.13 [0.78-1.65],0.5235409523297682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,24568,123,1.14 [0.96-1.36],0.1308439234015639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,21308,103,0.91 [0.73-1.14],0.4211417553653964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,20726,100,1.38 [1.04-1.85],0.0275463404300161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,20560,100,1.16 [0.81-1.67],0.4101085373734006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,21308,103,0.97 [0.79-1.20],0.7734460226208117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,23954,116,1.21 [1.06-1.38],0.0052234979212038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,20657,98,0.89 [0.66-1.20],0.4573637640400253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,20651,100,0.89 [0.42-1.88],0.7683133630861088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,24568,123,0.92 [0.72-1.17],0.4901744095224477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,24565,119,1.05 [0.88-1.26],0.5750944284292161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,23987,116,1.16 [0.90-1.49],0.2441130904186071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,24871,123,1.20 [0.74-1.96],0.4563682371436822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,20704,98,1.62 [1.11-2.38],0.0135157938030064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,20657,98,1.10 [0.87-1.39],0.4391645105268537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,21260,104,1.17 [0.75-1.81],0.4946143191363792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,24565,119,1.07 [0.85-1.36],0.5654505722829097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,20839,104,1.11 [0.57-2.16],0.7584194175553298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,24380,122,0.92 [0.65-1.32],0.6570429347145108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,24095,117,1.01 [0.68-1.51],0.9482868556707588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,20839,104,1.71 [0.82-3.57],0.1554375366443448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,21317,104,1.30 [0.79-2.14],0.3012520549104581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20704,98,1.71 [1.21-2.42],0.0021863711858482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,24142,117,0.79 [0.39-1.59],0.5067665412418034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,20657,98,1.37 [1.04-1.81],0.0265248371446548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,20726,100,1.40 [0.99-1.99],0.0578473064366392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,19989,96,1.10 [0.92-1.31],0.3072202145333683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,24528,122,1.20 [0.94-1.54],0.1525288149716582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,21284,104,1.05 [0.79-1.41],0.7206924609783505
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,21028,105,1.06 [0.89-1.26],0.5042391457640112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,20915,101,1.14 [0.63-2.07],0.6599508897575272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,20657,98,1.02 [0.58-1.80],0.9502445089541162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,20651,100,1.22 [0.90-1.64],0.1932875669544388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,20651,100,1.33 [0.80-2.20],0.2722779487781511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,23999,120,1.47 [1.03-2.08],0.0313800039696517
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,20657,98,0.77 [0.45-1.32],0.3479344580802664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,21284,104,1.16 [0.73-1.83],0.5299258377335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSG,Basigin,24830,124,3.42 [1.57-7.47],0.0020000433990072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSND,Barttin,20560,100,0.99 [0.55-1.77],0.9614170338300374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,24812,122,1.30 [0.86-1.97],0.2125960452130589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,24812,122,1.38 [1.08-1.77],0.0095976380676298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,23987,116,0.93 [0.74-1.17],0.5251353367482068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,21343,105,0.73 [0.30-1.74],0.4763701749135445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,20560,100,0.94 [0.74-1.19],0.5920934024272331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,21163,104,1.33 [0.93-1.91],0.1224544122334409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,24670,121,4.79 [2.88-7.97],1.720697669143049e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,24568,123,2.10 [1.52-2.91],7.661912329218118e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,20560,100,1.09 [0.68-1.73],0.7186200648039966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,23999,120,1.30 [1.07-1.58],0.0073622532195826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,20651,100,1.29 [0.74-2.25],0.3617138288310061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,24748,124,4.24 [2.25-7.98],7.773238059442873e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",21284,104,1.08 [0.84-1.38],0.5499735491818281
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,20704,98,1.30 [0.87-1.94],0.1946025285980529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,24632,120,1.24 [0.86-1.79],0.239444985492384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20839,104,0.56 [0.36-0.86],0.0080529625899973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,21284,104,1.04 [0.58-1.84],0.9033658994120782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,20800,104,0.83 [0.58-1.19],0.3145128451536541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,21343,105,1.06 [0.41-2.73],0.8964784849072458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,21307,105,4.99 [1.96-12.68],0.000735258494799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,21343,105,1.91 [0.83-4.40],0.1261397821936027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2,Complement C2,24603,120,0.97 [0.50-1.90],0.9333023957182168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,23952,120,1.49 [1.15-1.93],0.0026217253398245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,20725,96,1.29 [0.99-1.67],0.0549648170750787
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C3,Complement C3,20277,97,0.71 [0.43-1.18],0.1860275533227907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,24624,121,1.46 [0.99-2.16],0.0547053956008393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C5,Complement C5,21343,105,1.01 [0.30-3.39],0.9825128633763678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,20852,100,2.60 [1.46-4.64],0.0011758099996164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,21260,104,1.24 [0.65-2.35],0.5128533359183882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,21343,105,1.00 [0.55-1.83],0.9934902306897498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,21324,106,1.57 [1.10-2.25],0.0135012742874652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,21226,105,1.11 [0.89-1.39],0.340027143728722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,24000,118,1.11 [0.85-1.45],0.4434623324651867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,23987,116,0.84 [0.47-1.51],0.5657793186772353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,24459,123,1.76 [1.15-2.67],0.0085057612891598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,24296,123,0.97 [0.84-1.13],0.726448739073225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,24795,121,0.95 [0.60-1.50],0.834958553163758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,24494,119,1.10 [0.88-1.38],0.4108805816969764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,24829,123,1.10 [0.86-1.41],0.4548342125373983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,24871,123,1.25 [0.65-2.44],0.5038407738102683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",24142,117,1.16 [0.98-1.38],0.0782751810881507
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,24488,119,1.13 [0.87-1.45],0.3586842915073153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,20915,101,0.94 [0.53-1.67],0.8416005220152097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,20704,98,0.78 [0.34-1.80],0.557951312134968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,24795,121,1.20 [0.85-1.71],0.3054703482331178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,20725,96,1.00 [0.75-1.35],0.9751772716385678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,20657,98,0.78 [0.40-1.50],0.4565308515527058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,20651,100,0.83 [0.55-1.24],0.3545134200057818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,20657,98,1.14 [0.85-1.54],0.376752925201144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,21284,104,1.01 [0.81-1.26],0.9090286996861648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,20792,103,1.07 [0.89-1.29],0.459560426552815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,20725,96,0.81 [0.48-1.37],0.4241327888185187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,24459,123,1.22 [0.83-1.80],0.3066513817512827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,23999,120,1.22 [0.72-2.05],0.4571196550328029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,24374,122,1.23 [0.97-1.56],0.0945706898658817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,21260,104,1.07 [0.67-1.71],0.7911092491369336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,24725,121,1.06 [0.91-1.24],0.4458911578207917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,20726,100,1.33 [1.05-1.68],0.019207426987393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,20651,100,1.27 [0.85-1.91],0.2457793396837832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23987,116,1.37 [0.99-1.90],0.058696540689592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,20725,96,1.07 [0.76-1.53],0.6866489679384215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,21284,104,1.12 [0.95-1.33],0.1866747961361178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,24519,122,5.05 [2.31-11.03],4.868856466950366e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,24424,121,1.44 [1.13-1.83],0.0030528738438311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,21201,104,1.18 [0.76-1.83],0.4617740934220362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,21260,104,1.09 [0.92-1.30],0.3337285383939964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,23999,120,1.06 [0.78-1.45],0.7022075875530951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,20725,96,1.50 [1.00-2.24],0.0475020870258157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,23999,120,1.13 [0.91-1.41],0.2542633517139183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,23999,120,1.07 [0.86-1.35],0.5315994542811096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,24568,123,0.98 [0.78-1.24],0.8689894572830835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,24871,123,1.06 [0.88-1.26],0.55356444100942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,20915,101,1.01 [0.91-1.13],0.8237699171571546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,21260,104,1.14 [0.92-1.42],0.2336069104545179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,24732,121,1.11 [0.87-1.41],0.4101943208176138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,20704,98,0.98 [0.72-1.34],0.9117111276523346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,20651,100,0.70 [0.42-1.16],0.1631385807102899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAT,Catalase,20998,105,1.19 [0.85-1.65],0.3068093170226265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,24561,123,1.00 [0.79-1.25],0.9768030053397468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,20657,98,1.05 [0.87-1.26],0.6017854520144781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,24795,121,0.96 [0.58-1.58],0.8602740163892127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,20726,100,1.18 [0.84-1.65],0.3482022377177032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,20651,100,1.37 [0.96-1.94],0.0813123874493752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,24421,122,1.19 [0.97-1.46],0.1036136259707393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,21260,104,0.99 [0.71-1.38],0.9414720152655848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,21201,104,1.03 [0.71-1.49],0.8770191163582545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,20725,96,0.73 [0.37-1.42],0.3540789400336015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,21284,104,1.07 [0.86-1.34],0.5302465635416885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,24589,123,1.60 [1.00-2.56],0.0512863101488393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,20726,100,1.09 [0.80-1.47],0.5851219792233759
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,24879,125,1.16 [0.77-1.75],0.4699579735065986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,24839,125,0.90 [0.71-1.13],0.3487386686859686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,24471,119,1.38 [0.97-1.97],0.0747507901788917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,24871,123,1.37 [0.98-1.92],0.0666395502992222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,24871,123,1.35 [0.99-1.83],0.0569513673454891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,24505,120,1.22 [1.02-1.45],0.0270721964973664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,24208,119,1.14 [0.93-1.39],0.1981333996084698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,24812,122,1.12 [1.01-1.26],0.0393275762986651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,24380,122,1.17 [0.87-1.57],0.2971873884457885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,24879,125,1.08 [0.90-1.28],0.4164218452496018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,24670,121,1.41 [1.02-1.94],0.0375748222673665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,24280,120,1.44 [1.08-1.93],0.0128679470553792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,24670,121,1.48 [1.02-2.15],0.0403425651758121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,24635,121,1.24 [1.02-1.49],0.0272415447401539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,24879,125,0.93 [0.68-1.28],0.675298546777056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,24568,123,1.07 [0.91-1.27],0.3947248219207003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,24589,123,1.21 [0.94-1.57],0.137062750368198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,24495,123,1.07 [0.82-1.39],0.6312970068010435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,24568,123,1.27 [1.10-1.48],0.0013048461499795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,24581,120,1.09 [0.87-1.38],0.4514332717172566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,24632,120,0.94 [0.80-1.10],0.4197937320314089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,24568,123,1.03 [0.79-1.35],0.8259751572267319
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,24764,121,1.02 [0.78-1.32],0.8935351047437505
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,24425,123,0.87 [0.71-1.07],0.175389633721684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,24568,121,0.83 [0.63-1.10],0.1972704172351575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,24830,123,1.57 [0.99-2.49],0.0538399071011578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,24795,121,1.13 [0.77-1.67],0.5216249088175322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,24565,119,1.42 [0.94-2.13],0.0942376595683106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,20915,101,1.04 [0.62-1.73],0.8838455688735963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,20704,98,1.22 [1.07-1.41],0.0040997770926466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,24421,122,1.06 [0.76-1.48],0.7137211612116181
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,23987,116,1.17 [0.83-1.65],0.3715826460589353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,21226,105,1.00 [0.65-1.56],0.9919220212849498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,24565,119,0.99 [0.61-1.61],0.972266525206935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,24021,117,1.73 [1.19-2.51],0.0037501955018018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,24879,125,1.69 [1.22-2.33],0.0014040688834435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,24632,120,1.29 [0.90-1.85],0.169070881779624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,24565,119,1.05 [0.57-1.92],0.8742906537749296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,20725,96,1.21 [0.74-1.98],0.4569616297356454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,24530,119,1.26 [1.09-1.47],0.0020832848388396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,24624,121,1.31 [0.66-2.59],0.4438507588103625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,20651,100,1.53 [1.13-2.08],0.0058882447209193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,24568,123,2.05 [1.18-3.56],0.0112749824526631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,24487,123,1.01 [0.64-1.60],0.97268960430299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,24042,121,0.85 [0.55-1.30],0.4533932003207747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,24611,120,1.08 [0.72-1.62],0.7049486110254861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,24879,125,3.08 [2.25-4.22],2.005847611290179e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,20704,98,0.92 [0.58-1.46],0.7294621896387292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,24879,125,1.46 [0.82-2.58],0.1977877854935626
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,21308,103,0.97 [0.61-1.55],0.8918433474201446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,24624,121,3.89 [2.86-5.28],4.016767811515028e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,24421,122,2.75 [2.01-3.76],2.596171262526241e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,24550,121,1.75 [1.09-2.78],0.0194269552168802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,23987,116,3.44 [2.60-4.55],4.116433713899241e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,24589,123,1.08 [0.85-1.38],0.5279164846217566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,20839,104,2.86 [1.60-5.11],0.0003847346172001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,24812,122,1.57 [1.00-2.46],0.049089600335522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,24719,120,2.82 [1.99-4.00],5.755023651515545e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,24795,121,1.61 [1.20-2.17],0.0016938890694177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,24565,119,1.20 [0.77-1.87],0.4154178533709851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,24459,123,1.89 [1.14-3.12],0.0129407253400996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,24624,121,1.02 [0.83-1.25],0.8236788849550045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,24717,122,1.15 [0.59-2.21],0.6825514432651416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,20704,98,1.00 [0.66-1.51],0.9914892849149184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,24459,123,2.30 [1.39-3.80],0.0011663402514553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,20657,98,0.99 [0.57-1.74],0.9759490783716932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,20915,101,1.47 [1.11-1.96],0.0080005040920545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,20704,98,0.97 [0.77-1.21],0.7795182087911254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,24524,123,1.74 [1.18-2.55],0.0050714655099125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,24546,120,1.46 [1.09-1.95],0.011684896663336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,24879,125,0.90 [0.74-1.09],0.2704399669978364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,24386,119,1.83 [1.13-2.96],0.0133677585880305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,24635,121,3.08 [1.82-5.22],2.954324054530692e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,24764,121,3.31 [2.28-4.81],3.2398526625566357e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,23696,117,1.24 [0.67-2.30],0.4919444184867225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,24499,121,1.43 [0.57-3.59],0.444080700139313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,23648,113,2.41 [1.28-4.54],0.0063186251437325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,21230,102,2.23 [1.57-3.16],7.2635210871061e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,24830,124,1.23 [0.92-1.66],0.1674151549999369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,24380,122,0.91 [0.66-1.23],0.5294221532350057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,24454,121,0.99 [0.82-1.18],0.8756649695094342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,20670,98,2.23 [1.61-3.09],1.2148992919930342e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,24568,123,3.54 [2.73-4.59],1.6513954819904244e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,20839,104,4.80 [3.38-6.80],1.217192013045746e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,24812,122,4.16 [2.84-6.09],2.1587606088046138e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,24879,125,4.03 [3.21-5.06],3.135738194888857e-33
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,21317,104,5.88 [4.39-7.89],2.3581964077242915e-32
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,20915,101,0.98 [0.61-1.57],0.9384552277462136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,24568,123,4.67 [3.19-6.84],2.2170599578388215e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,24568,123,0.76 [0.46-1.25],0.2781687610468504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,21226,105,1.86 [1.00-3.45],0.0499022607020371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,24812,122,1.30 [0.95-1.80],0.1039627441121328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,23596,114,1.44 [0.84-2.45],0.1814754474153675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,24565,119,1.56 [0.67-3.61],0.2984533487708717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,24565,119,1.11 [0.56-2.17],0.7665530325455487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,21283,104,1.43 [1.03-2.00],0.0340605865591292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,21260,104,1.09 [0.49-2.41],0.8383299326236554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,20560,100,0.98 [0.72-1.33],0.8994273744910772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,20560,100,0.88 [0.53-1.46],0.624040874287084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,21190,105,1.06 [0.82-1.38],0.6659585370543041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,23987,116,1.26 [0.99-1.61],0.0657566407647945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,24624,121,1.00 [0.83-1.21],0.9904413145599328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,21226,105,1.08 [0.90-1.29],0.3994133622193544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,24421,122,1.82 [1.40-2.36],7.442597915679325e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,23713,117,1.01 [0.68-1.51],0.9528716357357973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,24765,122,1.08 [0.83-1.41],0.5565919006514537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,24589,123,1.09 [0.86-1.37],0.4797339350878257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,24589,123,1.52 [0.97-2.37],0.064710134601475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,20915,101,1.04 [0.54-2.03],0.8993348218020174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,21260,104,1.21 [0.62-2.36],0.5824941106537727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,24812,122,1.99 [1.31-3.02],0.0011974687382677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,20657,98,0.77 [0.49-1.23],0.2772893335709195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,24871,123,2.02 [1.24-3.28],0.0044188513598591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,24589,123,1.11 [0.73-1.67],0.6359610569580765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,23999,120,0.99 [0.68-1.46],0.9681766467310612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,24459,123,1.00 [0.80-1.24],0.9887597905388772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,24589,123,0.90 [0.60-1.34],0.6064400732196065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,20560,100,1.69 [1.02-2.81],0.0419756752210074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,21284,104,1.20 [0.92-1.57],0.1806346962251898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,20657,98,1.17 [0.85-1.63],0.3367973674320114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,24459,123,1.01 [0.87-1.17],0.8771453903824602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,24459,123,0.99 [0.84-1.17],0.9116140074319408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,24459,123,0.96 [0.58-1.60],0.8893243540083526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,24594,121,0.48 [0.27-0.86],0.0134949062681431
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,24797,124,1.18 [0.81-1.70],0.3869521752641741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,24586,121,0.96 [0.53-1.76],0.9001816688232449
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,21226,105,1.19 [0.95-1.49],0.1249042893336745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,20915,101,1.03 [0.79-1.35],0.8292314688397051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,21226,105,1.64 [1.06-2.51],0.0246202090676516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20915,101,1.55 [1.15-2.08],0.0042686624935274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,24568,123,1.22 [1.02-1.46],0.0255710201416457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,23987,116,1.12 [0.81-1.54],0.5050768452988625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23636,114,1.26 [0.97-1.63],0.0863738310237163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,21308,103,1.51 [1.05-2.17],0.0260227737405416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,24142,117,1.19 [0.87-1.64],0.2700692854968584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,20704,98,1.66 [1.28-2.14],0.00011384268276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,24142,117,1.27 [0.85-1.90],0.2345140403765851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,21308,103,1.20 [0.88-1.63],0.24705024764501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,24826,123,1.17 [0.89-1.53],0.2602794568255248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,20839,104,0.80 [0.41-1.59],0.5308124818236111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,20704,98,0.85 [0.44-1.64],0.6223620273711886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,20657,98,1.24 [0.97-1.59],0.0834297956888731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,20915,101,1.53 [1.16-2.03],0.002938688373743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,20915,101,1.11 [0.86-1.41],0.4243721240730945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,20651,100,1.26 [0.90-1.75],0.1740200894132249
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,20560,100,1.46 [1.08-1.98],0.014832717356027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,24128,118,1.10 [0.88-1.39],0.3916046407081712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,20726,100,1.11 [0.88-1.41],0.375812672676508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,23987,116,1.03 [0.82-1.28],0.8245970862994154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,20915,101,0.93 [0.63-1.36],0.6968104572196947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,20560,100,1.06 [0.64-1.77],0.8161173016378307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,23948,116,1.11 [0.88-1.40],0.386749745994507
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,23987,116,1.45 [1.15-1.82],0.001440674564768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,23999,120,1.02 [0.78-1.32],0.8970456441291252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,24611,123,0.78 [0.64-0.96],0.0176532379749067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,24459,123,0.76 [0.56-1.04],0.0834457918857853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,24459,123,0.79 [0.62-1.03],0.0788179918035714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,23999,120,1.04 [0.82-1.31],0.7593724433501401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,21226,105,1.08 [0.85-1.36],0.5312722876534137
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,20950,102,2.35 [1.32-4.18],0.0036893045130951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,23987,116,1.52 [1.18-1.96],0.0010194905614369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,21343,105,1.54 [0.68-3.46],0.2977084072566059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,20120,100,1.25 [0.55-2.82],0.5892682492220274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,21191,105,1.29 [0.90-1.83],0.1637411446511182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,21304,105,1.23 [0.94-1.61],0.1366588623032898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,21053,103,1.50 [0.94-2.40],0.0891436706747335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,21343,105,1.86 [0.74-4.63],0.185279463108265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFP,Properdin,21343,105,0.69 [0.29-1.65],0.4058444365421186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,24565,119,1.10 [0.90-1.35],0.3527507942920393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,21324,106,0.74 [0.46-1.20],0.224818627794525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,20725,96,1.28 [0.85-1.94],0.2352536664963195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,24589,123,1.35 [0.93-1.96],0.1109614876075419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,23987,116,1.20 [0.93-1.54],0.1632818208416769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,20839,104,0.70 [0.49-1.01],0.0561207158593317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21260,104,1.91 [1.35-2.69],0.0002155930453934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,21201,104,1.67 [1.04-2.67],0.0320241215823437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,24142,117,0.96 [0.59-1.58],0.8822756135256672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,21308,103,1.26 [1.04-1.54],0.0188985189950992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,24724,122,1.27 [0.85-1.90],0.2450826927001468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,23976,116,1.14 [0.93-1.40],0.2057254129990019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,24663,122,0.98 [0.89-1.09],0.7285718048390901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,24589,120,0.73 [0.43-1.25],0.2479861385225062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,20725,96,1.09 [0.79-1.49],0.6048588691982257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,24421,122,0.99 [0.81-1.21],0.9444505813475282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,21317,104,1.11 [0.80-1.53],0.5339981829570211
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,20657,98,1.11 [0.89-1.40],0.3528182292740986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,24635,121,2.09 [1.26-3.47],0.0043055686154488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,24589,123,0.94 [0.71-1.26],0.6928631880380982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,20725,96,0.97 [0.56-1.66],0.9022409009636848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,24624,121,1.05 [0.81-1.35],0.7223733769811922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,21308,103,1.00 [0.71-1.41],0.996338384320246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,20915,101,1.10 [0.74-1.64],0.6386467194672781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,21226,105,1.07 [0.88-1.30],0.4868326412931937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,20725,96,1.75 [1.32-2.33],0.000114642306184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,24741,123,3.09 [2.10-4.56],1.1549689321804097e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,21308,103,1.65 [1.21-2.25],0.0016342480652453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",24451,120,0.87 [0.70-1.08],0.2174232505355246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,20560,100,1.17 [0.94-1.47],0.16001675751727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,24553,122,0.88 [0.69-1.12],0.3052927810304491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,24421,122,1.46 [0.94-2.27],0.0887154346258839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,24518,119,1.01 [0.72-1.43],0.934659715753044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,20704,98,3.00 [1.82-4.94],1.6768629362962783e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,24565,119,2.06 [1.24-3.41],0.0050744439328897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,24142,117,2.67 [1.70-4.21],2.0948337320780635e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,24812,122,1.01 [0.86-1.19],0.9043153332374386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,20725,96,1.01 [0.70-1.47],0.95776335176811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,20854,100,0.55 [0.22-1.38],0.2040653795944139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,24568,123,0.70 [0.46-1.08],0.1044302597007766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,24568,123,1.21 [0.86-1.70],0.2737020708443544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,24568,123,1.04 [0.81-1.35],0.7454414769947166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,24568,123,1.64 [1.02-2.62],0.0397753556109215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,21273,103,1.05 [0.72-1.54],0.7864428513883865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,24498,122,2.01 [1.20-3.36],0.0081629825489713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,23987,116,1.74 [1.27-2.39],0.0005677746147002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,24879,125,1.20 [0.88-1.65],0.2457648595535678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,20725,96,1.05 [0.67-1.62],0.84469155479337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,20725,96,1.18 [0.68-2.04],0.5501628070944855
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,20560,100,0.76 [0.48-1.22],0.2593359248924715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,24568,123,1.00 [0.87-1.15],0.9851730872526268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,24795,121,2.31 [1.10-4.86],0.0270823759474716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,20725,96,1.16 [0.68-2.00],0.585533375072563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",24374,122,1.02 [0.87-1.20],0.8109613674052875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,24527,119,1.24 [0.99-1.56],0.0647390370367618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,23952,120,1.26 [0.88-1.80],0.1996267837926451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,23999,120,1.00 [0.72-1.37],0.9791725124472994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,24879,125,0.91 [0.60-1.37],0.6504041682754591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,21260,104,2.02 [1.31-3.13],0.0015995155025241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,24142,117,1.41 [1.04-1.89],0.0251573712985972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,21343,105,1.12 [0.67-1.87],0.6669573104359909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,24550,123,0.87 [0.61-1.23],0.423337624800002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,21317,104,1.08 [0.88-1.32],0.4712138464130594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,21201,104,1.12 [0.90-1.40],0.3126376066283464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,24632,120,0.74 [0.53-1.02],0.0696345691778665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,20657,98,0.78 [0.50-1.21],0.267544243059438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",20687,99,1.23 [0.97-1.56],0.0870722196271104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,24142,117,0.93 [0.69-1.25],0.6331257618579054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,24459,123,1.01 [0.82-1.24],0.9207894657389846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNST,Consortin,24589,123,1.02 [0.88-1.18],0.7976057769627993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,20657,98,0.83 [0.47-1.47],0.5195709262739756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,24871,123,0.73 [0.41-1.33],0.3039248186922401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,24795,121,1.13 [0.79-1.61],0.4933844833764418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,24565,119,0.48 [0.30-0.77],0.0025985281028738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,24565,119,0.47 [0.24-0.93],0.0298879518041032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,24646,122,0.81 [0.51-1.26],0.3466320488181313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,24568,123,1.10 [0.75-1.62],0.6124036782866817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,20725,96,1.15 [0.98-1.34],0.0832740029808491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,21317,104,1.49 [1.02-2.18],0.0369129857355316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,21308,103,0.95 [0.46-1.96],0.8827535140926268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,24648,121,2.57 [1.29-5.12],0.0073108578781871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,24871,123,0.61 [0.32-1.16],0.1342034970391492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,21226,105,1.05 [0.75-1.45],0.7802461454270188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,20725,96,0.98 [0.77-1.26],0.8756525570266425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,20726,100,1.01 [0.79-1.28],0.9573491248242264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,21308,103,1.63 [0.76-3.49],0.2101978981529005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,24589,123,1.59 [1.08-2.34],0.0192132344104483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,20880,101,0.88 [0.62-1.23],0.4509111864502786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,20839,104,1.13 [0.71-1.81],0.6076841919391907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,24871,123,1.79 [1.14-2.81],0.0120175847193402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,24568,123,1.14 [0.80-1.60],0.4692629743784597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,20915,101,1.25 [0.90-1.74],0.1905514906811122
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,24550,121,3.44 [1.91-6.17],3.564463555454951e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,20726,100,1.41 [1.05-1.88],0.021611589404169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,21201,104,1.47 [1.02-2.12],0.0374884423566154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,24292,119,0.89 [0.55-1.45],0.6479968507578032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,23867,116,1.12 [0.92-1.36],0.2596043526986177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',20651,100,1.07 [0.69-1.68],0.7532207214102449
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,23999,120,1.04 [0.74-1.46],0.8327381995990982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",20726,100,1.32 [0.91-1.90],0.1413328996694283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,24065,119,1.14 [0.96-1.34],0.1314935920470032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,20657,98,0.96 [0.57-1.63],0.8853835179551532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",24459,123,1.05 [0.84-1.31],0.6680748372232835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,21317,104,1.19 [0.68-2.07],0.5503694347588384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,24871,123,1.11 [0.86-1.44],0.4151105388819581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,24723,122,1.00 [0.78-1.27],0.9744743008745906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,20423,101,1.17 [0.75-1.84],0.4808414201131746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,24871,123,1.19 [0.92-1.54],0.1811841378258573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,21298,102,1.25 [0.55-2.82],0.5927180625762472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,24617,121,1.01 [0.67-1.53],0.9515327327506712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,20560,100,0.50 [0.25-1.00],0.0496637200307968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,24708,122,1.18 [0.76-1.83],0.4671449910945402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",20704,98,0.74 [0.35-1.53],0.4146794692115689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,24812,122,1.24 [0.99-1.56],0.0660758160069236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,21272,103,1.21 [0.72-2.02],0.4744330522625818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,20651,100,1.07 [0.68-1.68],0.781231474803695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,24753,121,1.38 [0.92-2.06],0.1227712499958463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,24624,121,0.84 [0.66-1.06],0.136919817166808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,21317,104,2.07 [1.03-4.17],0.0405158522514523
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,21239,106,1.76 [1.05-2.93],0.0307713387560474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,24632,120,1.87 [1.33-2.63],0.0003331318848114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,23987,116,1.20 [1.01-1.43],0.0346913277458473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,24374,122,1.05 [0.85-1.29],0.6651145812477268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,20560,100,0.71 [0.47-1.07],0.1046201719522576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,20560,100,0.59 [0.27-1.30],0.1910244036648157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,24220,119,1.17 [0.78-1.77],0.4490437981035992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,20839,104,1.44 [0.88-2.37],0.1464817688667554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,24635,121,1.17 [0.87-1.58],0.2909138974665993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,23946,116,1.22 [1.01-1.46],0.0356116056170256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,24550,121,1.44 [0.81-2.54],0.2142581146472285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,24142,117,1.03 [0.80-1.34],0.8096627898472353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,24670,121,2.39 [1.11-5.11],0.0250928964630804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,24421,122,1.66 [1.14-2.40],0.0074207557063916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,24795,121,1.21 [0.91-1.62],0.1910967545434348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,21118,106,0.93 [0.46-1.84],0.8260979439774029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,24584,121,1.02 [0.88-1.19],0.749333054350455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,24670,121,1.57 [0.84-2.92],0.1572182433331453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,23835,119,1.36 [1.06-1.73],0.0143055036245694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,24871,123,1.10 [0.65-1.87],0.7252499226364554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,24421,122,3.04 [2.28-4.07],5.3665544902283876e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,20725,96,1.17 [0.82-1.65],0.3873754313577789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,24142,117,1.09 [0.96-1.25],0.180316598466685
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,21317,104,1.19 [0.90-1.56],0.2144615586215191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,21260,104,1.07 [0.81-1.42],0.6391724231258307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,21260,104,0.94 [0.78-1.14],0.5556036040512922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,20657,98,1.23 [1.00-1.51],0.0475722416534202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,20726,100,1.15 [0.93-1.41],0.2036669605938361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,20651,100,1.15 [1.01-1.32],0.0388081868289491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,24670,121,4.41 [2.62-7.43],2.2113579139397744e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,21324,106,1.71 [1.16-2.52],0.0064197388348278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,20651,100,0.81 [0.46-1.42],0.4597991287512172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,24421,122,1.49 [1.21-1.84],0.0001838883561204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,20704,98,1.51 [0.97-2.37],0.0698165443148724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,24128,118,1.32 [0.95-1.82],0.0953483421450511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,20704,98,1.41 [0.83-2.41],0.2037964518860334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,21324,106,1.09 [0.62-1.89],0.7716695883319679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,20704,98,1.38 [1.07-1.77],0.011935555378807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,21284,104,1.15 [0.77-1.74],0.4937909111345094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,21308,103,1.43 [0.81-2.52],0.2139823825759201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,20657,98,1.37 [0.99-1.88],0.0538605242427538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,20651,100,1.08 [0.89-1.30],0.4328460623157467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,18465,92,1.08 [0.88-1.33],0.4619921376250553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,24591,120,1.93 [1.10-3.38],0.0216565852379852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,24134,121,1.51 [1.14-2.00],0.0039675519771089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,23951,115,0.83 [0.59-1.19],0.3150694152430549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,24581,120,1.16 [1.01-1.33],0.0403327433816036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,24229,120,1.53 [1.08-2.17],0.0159208930592104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,20869,101,0.91 [0.62-1.35],0.6550195256919695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,21029,105,1.75 [0.86-3.54],0.1202148555837205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,24142,117,0.98 [0.81-1.19],0.8482775746518274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,21308,103,1.41 [0.72-2.78],0.3148585602809346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,21308,103,1.23 [0.71-2.12],0.4633091915224011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,20657,98,0.58 [0.28-1.20],0.1435113737142951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,24565,119,1.12 [0.84-1.50],0.4414816672681486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,24550,120,1.18 [0.92-1.52],0.1948058139180964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,21260,104,1.19 [0.91-1.57],0.2070331321953258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,24560,122,1.32 [0.98-1.78],0.0722885950544306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,24499,121,1.25 [0.88-1.78],0.2097024312140989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,22904,113,1.03 [0.68-1.58],0.8771219099043627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,20839,104,0.98 [0.69-1.39],0.9035061325593414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,24624,121,1.21 [0.82-1.79],0.3435250768310518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,24073,115,1.30 [1.04-1.63],0.0215775240609752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,24589,123,3.21 [1.77-5.83],0.0001256970484961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,24879,125,2.04 [1.27-3.26],0.0032155858145811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,19417,97,2.02 [0.91-4.49],0.0846598746075022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,24721,121,0.46 [0.31-0.69],0.0001648136442258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,24540,120,2.72 [1.68-4.40],5.083865398282973e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,20725,96,1.22 [0.80-1.88],0.3525089885263385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,21109,105,1.41 [1.15-1.72],0.0008655695492373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,24421,122,1.85 [1.20-2.85],0.0052919384950594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,24568,123,1.10 [0.81-1.49],0.5487942055043987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,24499,120,1.07 [0.90-1.26],0.4435766448209151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,24670,121,1.41 [1.16-1.71],0.0005653437753102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,24812,122,1.31 [1.10-1.56],0.002176486225069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,24128,118,1.26 [0.85-1.87],0.2593955302994348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,24812,122,1.79 [1.63-1.96],1.8567585602092062e-34
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,24128,118,1.02 [0.79-1.32],0.8910339664543103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,24821,123,0.66 [0.33-1.33],0.2474737203152997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,24879,125,1.37 [0.99-1.88],0.05638600683229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,24546,120,1.00 [0.85-1.19],0.9603090865561786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,24504,123,0.94 [0.82-1.08],0.4059016187663414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,24879,125,1.12 [0.92-1.37],0.2589598358871841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,24384,121,1.11 [0.89-1.39],0.3513595556385811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,24670,121,1.81 [1.54-2.14],1.0417306895991809e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,20560,100,1.14 [0.90-1.43],0.2703929265245046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,20970,103,1.35 [0.99-1.83],0.0540126666305216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",20651,100,1.07 [0.87-1.32],0.5089884827072093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,20560,100,0.91 [0.68-1.20],0.4869409294027205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,21308,103,1.15 [0.52-2.55],0.7221458077160532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,20839,104,0.99 [0.79-1.24],0.8996199979521624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,24795,121,0.99 [0.86-1.14],0.9128336230709808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,24670,121,1.00 [0.72-1.39],0.9945335507226716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,20704,98,1.20 [0.90-1.58],0.2126450615686399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,20704,98,1.30 [1.00-1.70],0.0530302091514587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,24568,123,0.97 [0.86-1.11],0.6771360421140215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",24374,122,1.04 [0.83-1.29],0.7520403104756168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,21290,106,0.99 [0.84-1.16],0.886059643535137
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,24449,119,1.08 [0.88-1.32],0.4722064436391998
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,20704,98,1.58 [1.16-2.15],0.0037949543780735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,24670,121,1.06 [0.89-1.26],0.5101932916646732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",24624,121,1.77 [1.15-2.71],0.0092044702841633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,20725,96,0.88 [0.36-2.17],0.7858457590268316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,20560,100,0.89 [0.64-1.24],0.5036029139530572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,20560,100,0.88 [0.47-1.65],0.682380583241134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCN,Decorin,24142,117,1.32 [0.62-2.79],0.4744203631007787
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,20839,104,1.02 [0.83-1.24],0.8738342672154994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,24795,121,1.10 [0.86-1.40],0.4568139745201195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,24459,123,1.09 [0.93-1.29],0.2948340799458634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,23999,120,1.19 [0.97-1.45],0.0970279231606664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,24589,123,4.23 [2.80-6.40],7.747489162009246e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,20657,98,1.19 [0.96-1.48],0.1058734828985561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,20560,100,0.98 [0.77-1.25],0.8714494665139395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,24624,121,1.17 [0.88-1.55],0.286606704501809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,20651,100,1.11 [0.71-1.75],0.6434623639977943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24459,123,1.16 [0.82-1.62],0.4058690113728924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,24561,123,0.94 [0.68-1.30],0.7047378831755992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,21284,104,1.17 [0.89-1.55],0.260142792242455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,20839,104,1.03 [0.81-1.31],0.7935174773212774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,24812,122,1.42 [0.72-2.81],0.3060420187201876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,21308,103,1.39 [0.92-2.10],0.1226683432129056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,21226,105,1.17 [0.85-1.61],0.3431372702829971
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,20725,96,1.03 [0.62-1.71],0.9005287561852421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,20704,98,1.79 [0.91-3.54],0.0930304240522052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,20704,98,1.02 [0.72-1.43],0.9262403979469164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,20725,96,0.70 [0.40-1.23],0.2146746550475178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,23987,116,1.49 [1.23-1.79],3.269114974941693e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",24568,123,0.93 [0.79-1.10],0.4137026218574061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,24050,118,1.42 [1.10-1.84],0.0068903210079659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,20558,97,1.01 [0.63-1.61],0.9718245331709208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,20657,98,0.72 [0.48-1.08],0.1142999714996439
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,20657,98,0.97 [0.75-1.26],0.8413982258298267
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,20657,98,1.14 [0.87-1.51],0.3410783335499907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,24200,122,1.01 [0.90-1.12],0.8895529626112374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,20651,100,1.00 [0.68-1.48],0.9861377220162976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,20704,98,1.03 [0.74-1.43],0.8751574637924769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,24879,125,1.08 [0.86-1.35],0.5312452321121277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,20657,98,1.31 [0.93-1.84],0.1254837387133373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,20704,98,1.28 [0.91-1.80],0.1512810907281638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,24128,118,1.85 [1.28-2.67],0.0010429460805932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,20651,100,1.00 [0.66-1.52],0.9974317179517336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,21201,104,1.80 [1.39-2.34],1.022797384525411e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,21260,104,1.02 [0.69-1.50],0.9403259632611076
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",24498,122,0.95 [0.82-1.10],0.4948783986166472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,20725,96,1.48 [1.02-2.14],0.036877091160963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,20839,104,1.52 [0.87-2.65],0.1425079270970104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,24812,122,1.04 [0.80-1.36],0.7578048390329291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,24871,123,0.87 [0.50-1.50],0.609575684484533
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,24378,122,0.97 [0.69-1.38],0.879590641946691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,24459,123,1.10 [0.90-1.34],0.3401496639818582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,21260,104,1.14 [0.89-1.46],0.3115152153097372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,21284,104,0.77 [0.49-1.22],0.2713064346703361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,24871,123,1.06 [0.80-1.41],0.6681868686216521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,24624,121,3.96 [2.43-6.44],3.214913187492439e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,20726,100,0.86 [0.63-1.18],0.3511395864512069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,20726,100,1.24 [0.89-1.73],0.2048605447778874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,20726,100,0.83 [0.62-1.11],0.2202606537329062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,20560,100,0.66 [0.40-1.09],0.1079925630093074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,24790,124,1.02 [0.84-1.24],0.8252076733364686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,21260,104,1.19 [0.93-1.53],0.1687148362319026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,24459,123,1.03 [0.86-1.24],0.7276693992691992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,21226,105,1.28 [0.99-1.66],0.0611719683504692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,20839,104,0.99 [0.70-1.39],0.9334650537837024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,20640,103,1.05 [0.84-1.31],0.6643590565888731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,24142,117,1.14 [0.89-1.48],0.3050599585083939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,21260,104,1.71 [1.16-2.51],0.0062617785477688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,20726,100,1.19 [0.95-1.48],0.1277278095153317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,21226,105,1.18 [0.93-1.50],0.1703470465583459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,24513,120,0.49 [0.26-0.92],0.0264160509610689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,20657,98,1.14 [0.94-1.37],0.1749276377683321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,21226,105,0.93 [0.80-1.09],0.3943757279946229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,21284,104,1.34 [0.99-1.80],0.0579033825018715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,24421,122,1.28 [1.01-1.62],0.0405320489937666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,21260,104,0.97 [0.71-1.32],0.8491746387958348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,24619,121,1.09 [0.80-1.48],0.596927865142183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,20725,96,1.28 [0.86-1.91],0.2235178709413403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,20657,98,1.10 [0.95-1.27],0.2129969458344368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,21260,104,1.03 [0.90-1.19],0.6231262004306275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,24589,123,1.00 [0.88-1.14],0.9915135254069888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,24374,122,1.08 [0.77-1.51],0.6587896461029655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,24459,123,0.76 [0.44-1.33],0.3394331793974479
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,24568,123,0.91 [0.57-1.45],0.6884888154220221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,24061,117,0.63 [0.36-1.08],0.0949153022452583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,24459,123,1.13 [0.71-1.82],0.6067711357742023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,24384,122,1.21 [0.93-1.57],0.1483668047372799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,24871,123,2.04 [1.09-3.82],0.02644862387549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,24730,121,1.32 [1.05-1.67],0.0183967493678082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,24421,122,1.39 [0.96-2.02],0.0826430042086589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,24459,123,1.03 [0.78-1.36],0.8300290317601958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,24267,118,3.13 [2.09-4.68],2.678706229822232e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,21284,104,1.19 [0.71-1.99],0.5174535255406333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,24565,119,1.64 [0.90-2.97],0.1043675078224938
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,24724,121,0.94 [0.59-1.51],0.8115936723325041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,24369,123,0.89 [0.65-1.22],0.4749511433987773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,20839,104,1.05 [0.85-1.30],0.6576013766879237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,21165,104,1.70 [1.22-2.37],0.0017465410072495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,20725,96,1.07 [0.80-1.42],0.6557230979088844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,24459,123,2.20 [1.24-3.92],0.0072780916264657
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,21317,104,1.24 [0.96-1.62],0.1054247232430772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,24142,117,0.88 [0.68-1.14],0.3340901215545926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,21201,104,0.75 [0.47-1.19],0.2187490536030355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,20725,96,1.05 [0.79-1.39],0.742264939510622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,23999,120,0.90 [0.73-1.10],0.2965711821688668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",21226,105,1.06 [0.89-1.27],0.4968357188540132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,21260,104,1.44 [0.98-2.12],0.0668199494967742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,21201,104,1.19 [0.86-1.65],0.2913218019010826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,20725,96,1.17 [0.94-1.46],0.151724696177671
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,21201,104,1.26 [0.83-1.89],0.2758690247557169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,24421,122,1.06 [0.90-1.26],0.4829799394849864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,24763,121,2.66 [1.82-3.88],4.574140988628506e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,23999,120,0.98 [0.62-1.56],0.9293221996912552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",21317,104,1.16 [0.93-1.45],0.1941306831355597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",20726,100,1.12 [0.92-1.35],0.2557850662125242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,20651,100,1.33 [1.03-1.72],0.0313291393040115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,20738,99,1.01 [0.60-1.69],0.9788737195006768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,20657,98,1.13 [0.80-1.59],0.4925842864546935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,24795,121,2.79 [1.88-4.12],2.880009543323296e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,24568,123,0.82 [0.69-0.98],0.0256063084533299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,21201,104,0.86 [0.59-1.24],0.4249719372271446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,20651,100,0.82 [0.46-1.47],0.5074319186403776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,21284,104,1.26 [1.01-1.56],0.036299699490408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,24142,117,0.97 [0.61-1.53],0.8840068786567461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,20726,100,2.20 [1.19-4.08],0.0123941055879186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,20704,98,1.37 [1.01-1.88],0.0459077491396526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,21317,104,1.20 [0.99-1.46],0.0608357506198243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21226,105,2.00 [1.28-3.10],0.0021436800198591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,20915,101,1.21 [0.73-2.01],0.463017555930157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,24583,120,1.50 [0.89-2.52],0.1253571513536587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,21284,104,1.34 [0.83-2.16],0.2344209252454381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,24521,119,2.80 [1.66-4.74],0.0001202722409395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,24380,122,4.45 [2.99-6.62],1.7011867071213345e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,20725,96,1.07 [0.79-1.45],0.6605187654640481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,24508,120,0.97 [0.83-1.13],0.6825496915484622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,23987,116,1.47 [1.01-2.14],0.0428849901170579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,21226,105,1.45 [0.85-2.49],0.1769042896089878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,24871,123,0.35 [0.13-0.93],0.0343493065064995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,24568,123,1.35 [1.11-1.64],0.0028351843841861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,21317,104,1.12 [0.88-1.43],0.3635179002523888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,20726,100,0.97 [0.82-1.14],0.711027517660384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",21260,104,1.25 [0.94-1.65],0.1224939489883223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",21164,105,1.14 [0.97-1.34],0.1142086414302295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,20651,100,1.07 [0.80-1.42],0.6595192290576204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,20726,100,1.68 [1.19-2.37],0.0034488283032617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,24421,122,1.08 [0.82-1.43],0.5975732768595055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,20704,98,1.06 [0.86-1.32],0.5628102108277109
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,24589,123,1.17 [0.93-1.48],0.1847651535727935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,24879,125,1.07 [0.91-1.25],0.4003964124971939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,21284,104,1.10 [0.84-1.44],0.4813981975523064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,20651,100,1.11 [0.74-1.66],0.6289867060433669
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,24128,118,1.16 [0.69-1.95],0.5689399423583414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,21284,104,1.21 [0.98-1.51],0.0827485145250648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,20657,98,0.89 [0.69-1.14],0.3472769318996587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELN,Elastin,21317,104,2.24 [1.33-3.78],0.0024690040076726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,24459,123,1.23 [0.97-1.55],0.086159776690241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,20651,100,1.01 [0.62-1.65],0.956649931866036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,24128,118,1.13 [0.81-1.57],0.4864417038378652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,19699,95,0.88 [0.60-1.30],0.517653185436248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,24871,123,1.86 [0.73-4.70],0.1905065728608911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,24556,121,0.98 [0.80-1.20],0.8471826697268333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,24812,122,0.94 [0.74-1.19],0.601618455567817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,20726,100,0.87 [0.62-1.21],0.3949849224287005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,21201,104,0.97 [0.68-1.38],0.868219527513688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,20651,100,1.34 [0.72-2.51],0.3579553398930342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,20651,100,0.84 [0.50-1.41],0.5201922905580879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,24871,123,1.53 [0.87-2.69],0.1418883590954608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,24670,121,0.75 [0.56-1.00],0.0477827165232365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,20726,100,0.75 [0.45-1.27],0.290602817365353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,23852,117,0.95 [0.79-1.15],0.6125984675426068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,21201,104,1.02 [0.72-1.45],0.8924639197865502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,23987,116,1.06 [0.73-1.54],0.7759098761095816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,24142,117,1.27 [0.59-2.76],0.541667189798851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,24142,117,1.18 [0.62-2.22],0.615048627330133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,20726,100,1.02 [0.75-1.39],0.8835746021804265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,20704,98,1.30 [0.75-2.27],0.3529580163754084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,20725,96,1.06 [0.80-1.40],0.7017178312234145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,24554,121,1.04 [0.88-1.23],0.672894653192435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,21201,104,0.95 [0.63-1.44],0.8176220487981731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,24619,121,1.63 [1.00-2.66],0.0514855261796687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,23999,120,0.91 [0.69-1.20],0.4996428249462473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,23699,118,2.88 [1.86-4.47],2.3721502874084284e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,20839,104,2.41 [1.26-4.62],0.0080487748239192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,24871,123,2.31 [1.28-4.15],0.0053595978372461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,24374,122,3.13 [1.91-5.12],5.557412304603294e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,24142,117,1.13 [0.89-1.44],0.314808285743955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,20915,101,1.04 [0.67-1.61],0.8580293279260494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,24568,123,1.12 [0.93-1.36],0.2442733385422296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,20726,100,1.32 [1.05-1.65],0.0177378006535398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,24762,121,1.63 [1.00-2.66],0.0516609056448375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,24624,121,0.63 [0.35-1.12],0.1174185744439965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,24454,120,0.95 [0.42-2.19],0.912767185496786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,24624,121,0.79 [0.41-1.52],0.4809990068835122
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,24459,123,1.00 [0.86-1.16],0.9706403343668878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,20725,96,0.96 [0.73-1.26],0.7554958980686804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,20560,100,0.84 [0.44-1.59],0.5849399004063329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,24374,122,0.94 [0.77-1.15],0.5536404742393654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,20915,101,1.41 [0.87-2.28],0.165934091161793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,20704,98,1.20 [0.78-1.83],0.4025462473013371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,21201,104,1.18 [0.74-1.89],0.4828573884908703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,20839,104,1.00 [0.85-1.17],0.970991628539677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,24425,123,0.74 [0.40-1.36],0.3310115223715031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,20651,100,0.91 [0.59-1.41],0.6808792879786993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,24871,123,1.50 [0.93-2.42],0.0995308815696376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,24550,121,0.99 [0.62-1.59],0.983345371914324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,20560,100,1.11 [0.81-1.53],0.5216508369799632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,20704,98,1.31 [1.04-1.66],0.0243159765457968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,21260,104,1.16 [0.93-1.44],0.195523243392111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,20560,100,0.99 [0.61-1.60],0.9640300344424196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,20704,98,1.03 [0.84-1.28],0.7613774473443716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,20915,101,1.07 [0.60-1.90],0.8209325511653899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,20651,100,1.11 [0.84-1.47],0.4692005016112742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,20651,100,1.20 [0.85-1.70],0.2882440957248618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,24812,122,2.82 [1.57-5.07],0.0005008356931259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,21324,106,0.82 [0.40-1.69],0.5927723348898538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,21031,101,0.93 [0.50-1.73],0.8243435802822351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,24565,119,1.12 [0.84-1.48],0.441738714836782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,21343,105,0.88 [0.57-1.37],0.5729109967248265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,21230,102,1.48 [0.72-3.04],0.2821863484996482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,21343,105,2.45 [0.73-8.29],0.1482936816116711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,24635,121,1.11 [0.85-1.46],0.434790834011116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,24639,121,1.45 [0.82-2.57],0.2037135002090635
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,24591,119,1.12 [0.65-1.92],0.6908984814821929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,24603,120,0.95 [0.39-2.30],0.9139249438397756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",24550,121,1.23 [1.04-1.44],0.0127246718547699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",24589,123,1.26 [1.04-1.52],0.0184365853497994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",21317,104,1.50 [1.10-2.05],0.0101774197828359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",24871,123,1.35 [0.99-1.84],0.0598358191192751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,24744,121,1.15 [0.92-1.45],0.2235228179158767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,24109,117,1.34 [1.02-1.75],0.0360642780223206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,24568,123,0.94 [0.71-1.25],0.6693821175784525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,24589,123,1.02 [0.83-1.25],0.8434814778673612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,21226,105,1.09 [0.84-1.42],0.524311028405359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,21284,104,0.94 [0.83-1.07],0.3526088319902022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,21201,104,1.39 [0.80-2.42],0.2415435423707771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,20726,100,1.20 [0.89-1.63],0.2306792164861399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,21317,104,1.19 [0.62-2.29],0.606272048877665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,24459,123,1.00 [0.65-1.55],0.9987178503710776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,24561,123,2.12 [1.25-3.58],0.0050976741644016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,21226,105,1.02 [0.82-1.27],0.8830710466537741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,24871,123,0.73 [0.41-1.30],0.2881827491850102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,20725,96,1.24 [0.97-1.60],0.0884275963747272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,24780,122,1.63 [1.23-2.16],0.0007547503388235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,24879,125,0.87 [0.57-1.32],0.5117726146450496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,21308,103,1.99 [1.10-3.59],0.021943083821334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,20725,96,1.26 [0.93-1.71],0.1338031737721824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",24589,123,1.00 [0.80-1.23],0.9644463436834776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,21317,104,2.70 [2.23-3.27],2.0901062121945508e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,24568,123,1.11 [0.79-1.55],0.5488881475655458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,21284,104,0.81 [0.37-1.74],0.5864323558925915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,24565,119,2.60 [2.11-3.20],2.365213991870046e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,24437,119,1.03 [0.79-1.36],0.8095547437294176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23987,116,0.97 [0.73-1.29],0.8194134559379658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,24551,119,0.79 [0.58-1.08],0.144726569136827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,21290,106,1.17 [0.83-1.67],0.3703042304307216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,24434,120,1.22 [0.81-1.84],0.3390484196676643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,24589,123,2.45 [1.76-3.41],9.186327326562068e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,24771,124,3.07 [2.53-3.73],7.00313563519373e-30
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,24128,118,1.82 [1.37-2.43],3.770223344106889e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,24565,119,1.41 [1.06-1.87],0.0168687847455795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,24568,123,1.42 [1.12-1.81],0.0044164780697417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,23987,116,1.53 [1.25-1.88],3.754295293429642e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",20651,100,1.24 [0.98-1.58],0.0755768355602639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",20651,100,1.28 [0.95-1.71],0.1049866795891922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,23987,116,1.20 [0.99-1.45],0.0581192605279878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,23987,116,1.03 [0.73-1.46],0.8494157818020516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,24603,120,1.34 [0.81-2.22],0.2478761607693923
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,20844,101,2.12 [1.20-3.77],0.0098489562772509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",21284,104,1.18 [0.95-1.48],0.1409773661664357
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,20704,98,0.89 [0.55-1.45],0.6397543242764865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,20704,98,1.06 [0.71-1.58],0.7685523166367696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,24670,121,0.92 [0.75-1.12],0.3999265058445425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,24568,123,1.19 [0.95-1.49],0.1289387019163457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,20704,98,1.19 [0.81-1.75],0.3794249384660986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,24763,121,1.06 [0.93-1.21],0.3599565882894887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,24757,121,1.16 [0.91-1.49],0.2382425154252278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,20704,98,0.85 [0.43-1.71],0.656470277173015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,24128,118,1.27 [0.80-2.04],0.3101076271925396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,20704,98,1.18 [0.82-1.71],0.3784955104827986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,20560,100,1.03 [0.82-1.30],0.78393343775843
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,20517,100,1.26 [0.78-2.03],0.3364785433762651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,24624,121,0.74 [0.46-1.20],0.2213269443301873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,21308,103,0.59 [0.41-0.86],0.0055006413555766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,21260,104,1.42 [0.86-2.33],0.1709113304624751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,24624,121,0.53 [0.26-1.08],0.0790530813505102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,20839,104,0.79 [0.56-1.13],0.2059630773282061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,21324,106,1.31 [0.98-1.75],0.0729173308030446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,23999,120,1.21 [0.97-1.50],0.0841002225037867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",20657,98,1.27 [1.07-1.50],0.0056047822802842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,20651,100,1.12 [0.78-1.62],0.5405952499933802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,23999,120,0.94 [0.76-1.18],0.6058680251535724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,24530,120,1.04 [0.85-1.28],0.6931367809470124
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,21284,104,1.04 [0.87-1.26],0.6586969154559521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,24681,124,1.00 [0.87-1.15],0.9789012189146782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,24421,122,1.33 [0.92-1.91],0.1259819354059308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,24421,122,1.06 [0.90-1.26],0.4667056515152584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23952,120,1.45 [1.16-1.82],0.0011264921025535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,21226,105,1.06 [0.77-1.44],0.7340139213987478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,23987,116,1.05 [0.90-1.21],0.5336949817815606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,24421,122,2.03 [1.21-3.41],0.0073015158158944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,24418,123,0.67 [0.31-1.46],0.3166927315463868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,23987,116,1.41 [0.92-2.15],0.1101033441325325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,24879,125,2.14 [1.35-3.38],0.0012161387581034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,24624,121,1.11 [0.70-1.78],0.6537225600824534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,23999,120,1.08 [0.86-1.35],0.5166076909958053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,23987,116,1.16 [0.73-1.84],0.5234250120043384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,21343,105,0.57 [0.28-1.16],0.1196851282580299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,21260,104,0.81 [0.55-1.20],0.2944088434787772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,21201,104,1.76 [1.23-2.51],0.001831108865048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,20704,98,1.18 [1.04-1.35],0.0106471537449629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,24504,120,2.61 [1.55-4.37],0.0002904222215351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,24812,122,2.05 [1.21-3.48],0.0076398434295002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,24547,121,1.01 [0.94-1.10],0.7382028202950444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,20517,100,1.17 [0.70-1.98],0.5476112885529683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,23999,120,1.38 [1.04-1.83],0.0248499721472025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,20704,98,1.55 [1.12-2.15],0.0077250029292816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,24568,123,1.14 [0.95-1.36],0.1740079756337989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,23987,116,1.18 [1.02-1.37],0.0303677559640302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,20651,100,1.11 [0.85-1.45],0.4503151365579001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,20725,96,0.74 [0.41-1.32],0.3075645279873865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,24345,122,1.13 [0.62-2.06],0.6916075212348043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,20726,100,1.39 [1.03-1.87],0.0315031643304766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FST,Follistatin,24635,121,0.82 [0.59-1.14],0.2430432712266219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,20726,100,2.31 [1.04-5.12],0.0390899721545663
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,24514,120,2.03 [1.25-3.32],0.0045388213043395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,21224,104,0.99 [0.79-1.22],0.8935528128051156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,24699,120,1.17 [0.95-1.46],0.1441490288582194
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,20839,104,1.09 [0.82-1.45],0.555095903077258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FURIN,Furin,24624,121,0.66 [0.42-1.05],0.0814796716979466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,23949,116,1.45 [1.00-2.10],0.0475712669046313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",20880,101,0.95 [0.69-1.30],0.7320801853311905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24812,122,1.74 [1.23-2.46],0.0016495742248901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",24421,122,1.06 [0.81-1.39],0.6610034188846772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",24795,121,0.95 [0.76-1.18],0.6156055712334069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,24128,118,0.97 [0.75-1.25],0.8134288920861019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,24527,119,1.01 [0.85-1.20],0.9269333563748696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,20725,96,1.13 [0.86-1.50],0.3780813314469538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,20657,98,1.34 [0.93-1.94],0.1188425896384399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,21201,104,1.76 [1.38-2.24],4.691401390294227e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,20915,101,1.09 [0.84-1.42],0.5121243689291002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,20657,98,0.91 [0.66-1.26],0.5696707473913949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,20560,100,0.92 [0.44-1.91],0.8136922132895663
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,20704,98,1.20 [0.84-1.71],0.3155471291224999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20915,101,1.46 [1.18-1.80],0.0004156618826847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,20726,100,1.20 [0.86-1.69],0.2849948901885464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,20560,100,1.01 [0.74-1.37],0.9650357136722664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,24670,121,0.71 [0.55-0.91],0.0063742769750812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24459,123,2.57 [1.55-4.27],0.0002560869834426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,24795,121,1.39 [0.75-2.57],0.3019557155359494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,24128,118,1.64 [1.13-2.38],0.0097026571007499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,21317,104,1.07 [0.55-2.09],0.8447892997942849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,24459,123,1.05 [0.49-2.27],0.9021037280857208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,20651,100,1.14 [0.70-1.83],0.6042036845832717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,20393,101,1.14 [0.62-2.09],0.6729318923680593
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,21284,104,0.70 [0.32-1.56],0.3886896130431678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,20915,101,1.06 [0.75-1.50],0.7338268681501257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,24692,121,0.99 [0.53-1.84],0.9654512172766818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,20651,100,0.77 [0.50-1.20],0.2525089540298553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,21260,104,1.04 [0.90-1.21],0.5894008443146779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,20560,100,0.99 [0.48-2.05],0.9785892163413148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",20726,100,1.16 [0.92-1.46],0.2187606686639299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,20725,96,1.10 [0.77-1.56],0.6011703361803408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,21221,104,1.65 [1.30-2.10],3.372711385039925e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,24128,118,1.34 [1.06-1.71],0.015732975477627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,23999,120,0.95 [0.68-1.33],0.7587063629058757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,20651,100,0.82 [0.50-1.33],0.4258322610131931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,21343,105,1.05 [0.52-2.13],0.8965588640095151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,21260,104,1.05 [0.88-1.25],0.5847358860283902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,23987,116,0.93 [0.81-1.06],0.2862516157200671
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20326,101,1.66 [1.27-2.16],0.0001864507910399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,20651,100,1.28 [0.91-1.80],0.1533365449423896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",24459,123,2.74 [1.80-4.17],2.361873255128513e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,24871,123,1.82 [1.46-2.26],7.420703135701404e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,24589,123,0.74 [0.47-1.17],0.1974548054397192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,23999,120,1.67 [1.15-2.44],0.0077387208777661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,21317,104,1.08 [0.78-1.48],0.6553440605917985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,23952,115,1.18 [0.81-1.70],0.3841779798570559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,23987,116,1.32 [1.04-1.68],0.0246222549956244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,23987,116,0.96 [0.83-1.10],0.524317057380254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,24763,121,2.22 [1.27-3.88],0.005319075141153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,24459,123,1.56 [0.73-3.34],0.2542111995364632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,24340,122,1.34 [0.76-2.37],0.3135831705528025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,20652,102,1.31 [0.99-1.73],0.0567675607787726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,23999,120,0.90 [0.70-1.15],0.4021774293082143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,21317,104,1.13 [0.87-1.46],0.3488364727007468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,21280,104,1.28 [0.89-1.85],0.1768679362530592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,24111,116,1.23 [0.77-1.95],0.3904872881897374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,24521,119,1.13 [0.83-1.54],0.4504775850181521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,24421,122,1.11 [0.56-2.21],0.7603584266678179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,24561,123,1.06 [0.97-1.15],0.2070734357702432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,23987,116,1.01 [0.91-1.11],0.8884092351180863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,20839,104,0.50 [0.26-0.95],0.0336228609417676
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,23999,120,0.80 [0.57-1.13],0.2081659131488769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,24589,123,0.95 [0.78-1.16],0.6251393816522952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,21284,104,1.09 [0.64-1.86],0.7456815145886937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,21284,104,1.32 [1.06-1.65],0.0148757281352402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,20839,104,1.53 [0.99-2.38],0.0583618267007604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,20560,100,1.42 [1.05-1.92],0.0230949877668227
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,20726,100,0.91 [0.59-1.40],0.6658578803012241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,21260,104,2.42 [1.43-4.08],0.000917879910406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,21226,105,1.00 [0.83-1.21],0.9650037504310474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,20704,98,0.87 [0.55-1.38],0.5528656615829733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,20704,98,1.09 [0.89-1.33],0.4196823690721381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,20560,100,1.30 [1.04-1.63],0.0236088614275723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,23534,119,1.67 [0.95-2.92],0.0754184425432433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,20792,103,1.23 [0.75-2.00],0.4122446545405961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,24421,122,1.16 [0.80-1.67],0.4430370189610451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,20704,98,1.63 [1.13-2.36],0.0088283341765868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,24142,117,1.14 [0.86-1.51],0.3499120968885102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,24495,120,1.32 [0.85-2.07],0.2198397047184994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,20657,98,1.28 [0.83-1.96],0.2639324050064344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,24436,122,1.31 [1.01-1.71],0.0435222327172567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20839,104,1.13 [0.92-1.39],0.2333683041838828
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,23999,120,1.20 [0.91-1.59],0.2049918584405749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,21201,104,1.12 [0.84-1.48],0.4406344084043866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,20804,101,1.66 [1.25-2.20],0.0004419475169017
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,21317,104,1.14 [0.88-1.47],0.331762213510531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,24879,125,1.07 [0.78-1.47],0.6683275669252611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,20839,104,1.16 [0.88-1.52],0.3069480703909963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,21284,104,0.96 [0.77-1.19],0.7102488651107663
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23987,116,0.97 [0.75-1.25],0.7947383525454342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,20725,96,0.98 [0.67-1.44],0.9209998442247754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,24565,119,1.40 [1.03-1.91],0.0304950872096684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,20726,100,1.44 [0.94-2.19],0.0930665385147485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,20839,104,0.96 [0.58-1.60],0.8819945214840159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,21284,104,1.20 [0.96-1.51],0.1144098621165143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,24812,122,2.55 [1.35-4.82],0.0039199773034097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,24568,123,0.97 [0.83-1.13],0.7014990181156782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,21226,105,1.17 [0.80-1.71],0.4285729686341186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",21308,103,1.36 [0.92-2.04],0.1271916352937981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,24442,120,0.86 [0.52-1.41],0.547482110499391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,20651,100,1.06 [0.80-1.41],0.6652035852862717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,23823,112,1.05 [0.86-1.27],0.6542634320315273
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,20839,104,0.84 [0.51-1.39],0.4915407418415094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,24527,119,1.05 [0.88-1.26],0.5799501574451407
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,24459,123,1.04 [0.93-1.18],0.4828306765018307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,24795,121,0.94 [0.54-1.63],0.8198641524911255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,24421,122,0.75 [0.57-1.00],0.0500973772507104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,21201,104,0.90 [0.63-1.28],0.5670409915086695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,21226,105,1.35 [1.01-1.81],0.0422613403125867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,21324,106,1.40 [0.98-2.00],0.0634911138377607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,21226,105,1.32 [0.99-1.76],0.0580169683924884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,23999,120,1.59 [1.08-2.32],0.0180344564213217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,23931,121,1.35 [0.76-2.40],0.2998389414571689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,20657,98,1.09 [0.83-1.44],0.5285817126704109
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,21284,104,1.16 [0.72-1.87],0.5436864445922128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,21226,105,1.18 [0.88-1.57],0.2650771726816041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,24142,117,1.21 [0.94-1.57],0.1424168415095825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,21201,104,1.05 [0.77-1.43],0.7738172958365143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,24589,123,0.99 [0.87-1.12],0.8361864253610553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,21317,104,1.16 [0.87-1.55],0.3032493004328429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",21284,104,0.98 [0.61-1.58],0.9436253448446016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",20657,98,1.00 [0.70-1.42],0.9821305124795556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,24142,117,0.98 [0.71-1.35],0.9150805456976624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,24446,119,2.67 [1.49-4.78],0.0009945993881716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,20726,100,0.96 [0.67-1.39],0.8418544962808983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",24459,123,1.33 [1.06-1.67],0.0134842792509883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,20443,100,1.14 [0.91-1.42],0.2666814771527317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,23987,116,1.10 [0.94-1.30],0.2459719718099298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,21238,106,0.60 [0.23-1.59],0.3074673433260379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",21203,106,2.56 [1.16-5.65],0.0198275922225139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,24553,122,1.01 [0.84-1.22],0.8956414756207616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,23987,116,0.91 [0.73-1.13],0.3984478291048847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,20651,100,1.01 [0.77-1.31],0.9567193321498852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,23845,119,1.03 [0.81-1.29],0.8273755524366477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,21260,104,1.01 [0.94-1.09],0.7754358717419563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,20915,101,0.97 [0.74-1.28],0.8298370881122886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,20725,96,1.13 [0.89-1.44],0.307081820658092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,24446,119,1.28 [0.77-2.11],0.3402528941303293
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,20915,101,1.06 [0.86-1.32],0.5615834257113381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,20651,100,1.33 [0.96-1.85],0.0872547084425152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,24657,120,0.95 [0.73-1.25],0.7264138611929278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",24142,117,0.97 [0.82-1.16],0.7605326655758444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,24879,125,2.43 [1.74-3.39],1.8597314004792128e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,24568,123,0.72 [0.55-0.94],0.0169927563290747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,24142,117,1.28 [1.09-1.50],0.0023716710201965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,20560,100,1.21 [0.89-1.64],0.2264340676863171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",20651,100,1.08 [0.82-1.41],0.6037263366087557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",24732,121,1.10 [0.88-1.36],0.4105731552076535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,24795,121,1.01 [0.89-1.14],0.8644361099844852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",24565,119,1.07 [0.87-1.31],0.5326641130551304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,24764,121,1.41 [1.10-1.80],0.0065717242000579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,24565,119,2.33 [1.55-3.50],5.283857660459036e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,24732,121,0.85 [0.69-1.06],0.149382884916243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,24795,121,1.10 [0.86-1.42],0.4358675716923794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,21317,104,1.03 [0.87-1.23],0.699245535153342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,20651,100,1.32 [1.06-1.63],0.011149589187146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,24879,125,1.07 [0.81-1.42],0.6374661750447086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,20704,98,1.39 [1.15-1.68],0.0007848986026013
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,20657,98,0.89 [0.63-1.25],0.4974323574832446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,21226,105,1.53 [1.06-2.21],0.0240297296775196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,24765,121,1.06 [0.90-1.26],0.4775514915602793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,21260,104,1.46 [1.15-1.86],0.0018918035985595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,24142,117,0.97 [0.71-1.31],0.8296525057843095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,20839,104,1.45 [0.73-2.86],0.2902778136425351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,21260,104,0.93 [0.60-1.45],0.7521629906976088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,21317,104,1.05 [0.52-2.08],0.8985421423591283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,24568,123,1.11 [0.91-1.34],0.3091453687383148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,24879,125,1.22 [0.78-1.91],0.3749266499955652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,21124,103,0.58 [0.31-1.10],0.0955741904149535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,23987,116,1.00 [0.81-1.23],0.9899951453804968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,21260,104,1.11 [0.87-1.41],0.4024443729854513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,20704,98,1.17 [0.93-1.47],0.1894287666929065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,20651,100,1.41 [0.93-2.13],0.1065363047327221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,21225,103,1.56 [1.27-1.91],2.574371378965255e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,21284,104,0.99 [0.65-1.52],0.981557071693372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,24142,117,1.21 [0.68-2.16],0.5197266759654905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",21284,104,1.58 [0.88-2.83],0.1257904735100184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",24485,123,1.28 [0.83-1.97],0.2661599682645899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24568,123,2.74 [1.72-4.37],2.3109012417718148e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,24795,121,1.13 [0.79-1.64],0.4989009832871471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,20797,104,1.33 [0.95-1.86],0.0954671272111928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",20726,100,1.23 [0.87-1.74],0.2462708562602018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",20651,100,0.96 [0.62-1.49],0.8529108598395785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,20524,100,0.89 [0.58-1.37],0.6024263034131931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,24313,122,1.30 [0.94-1.80],0.1160508189072864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,23999,120,1.42 [1.09-1.85],0.0097985098095001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,20725,96,1.21 [0.99-1.48],0.0588256473282709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,24299,122,1.75 [1.27-2.40],0.0005263865450793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,24055,116,1.03 [0.84-1.27],0.7584393703842516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,21284,104,1.43 [1.07-1.91],0.0161408750966639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,24879,125,1.01 [0.82-1.25],0.9334643148354074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,23987,116,0.91 [0.58-1.42],0.6700101397323028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,21028,102,1.20 [0.98-1.47],0.0731842116832033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,20886,101,1.03 [0.86-1.24],0.7538072777520203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,20726,100,1.89 [1.31-2.73],0.000652093265999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,21230,102,1.13 [0.63-2.04],0.6879133624959337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,20726,100,1.19 [0.96-1.46],0.1047046767627074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,24459,123,1.19 [0.78-1.81],0.4162784389595183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,24795,121,1.70 [1.17-2.47],0.0052740215437014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,20704,98,1.52 [0.88-2.62],0.132005841075711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,20726,100,1.14 [0.94-1.39],0.1840676334846891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,24568,123,1.21 [0.81-1.81],0.3397928231404062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,21260,104,1.14 [0.85-1.53],0.3832179658481651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,20651,100,1.35 [0.97-1.87],0.0751770100466282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,20726,100,1.83 [1.30-2.59],0.0006234647267567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,23894,119,1.06 [0.84-1.32],0.6399235571684003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,24619,121,1.10 [0.88-1.36],0.4038498008130188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,21201,104,1.64 [1.21-2.24],0.0016986139034737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,24169,120,0.93 [0.74-1.16],0.5167492655772683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,24795,121,1.40 [0.94-2.08],0.0947937345615881
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,24356,119,1.61 [0.88-2.97],0.124831231850479
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,20657,98,1.09 [0.87-1.37],0.4419232289581601
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,20657,98,1.28 [0.86-1.90],0.2315697072582573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",24624,121,1.06 [0.82-1.37],0.6384083201016313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,24395,120,0.90 [0.45-1.83],0.77735861774135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,24871,123,2.91 [1.44-5.91],0.0030397822968947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,24128,118,1.06 [0.86-1.29],0.597168376729272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,24441,119,2.11 [1.25-3.55],0.0049960821960972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,24871,123,1.44 [0.86-2.40],0.1643885173088279
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,24871,123,6.05 [3.77-9.70],8.865238807190018e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,24568,123,0.74 [0.55-0.99],0.0417117378473222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,24589,123,0.85 [0.60-1.20],0.3467315539928896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,24459,123,0.91 [0.39-2.12],0.8321395037077771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,20915,101,0.88 [0.55-1.40],0.5857077548460801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,23999,120,1.42 [1.06-1.91],0.0182543444486314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",20726,100,1.37 [1.06-1.78],0.0176275788408591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,24879,125,0.88 [0.15-5.19],0.8887287104265943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,24795,121,1.04 [0.74-1.46],0.8249373994154566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20741,98,2.80 [1.94-4.04],3.2783727806649804e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,20915,101,1.08 [0.75-1.55],0.6655727702764377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20915,101,1.68 [1.14-2.48],0.0090563483776476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,21226,105,2.05 [1.19-3.52],0.0093257403444207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,24128,118,1.21 [1.05-1.39],0.007645064041029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,24670,121,2.94 [1.78-4.85],2.3975161728099683e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,24421,122,0.79 [0.58-1.09],0.1529331674395636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,23999,120,1.65 [1.23-2.21],0.000843415036645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,20657,98,0.93 [0.67-1.29],0.654297360698392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,24568,123,1.93 [1.49-2.51],7.574851785123887e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,20651,100,1.11 [0.68-1.81],0.6788760610832313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,20725,96,1.16 [0.77-1.77],0.4788509237580827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,21284,104,1.17 [0.87-1.58],0.303758187514014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,20657,98,1.21 [0.88-1.66],0.2375419837149219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,21308,103,0.40 [0.24-0.69],0.0008917322229315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,24459,123,1.46 [0.80-2.66],0.2175035346111315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,20651,100,1.12 [0.76-1.63],0.568003205436059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,24565,119,1.45 [0.74-2.86],0.2793017087057262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,24829,123,1.04 [0.91-1.18],0.561891151537834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,24824,123,1.48 [1.15-1.91],0.0027047801189654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,24632,120,0.86 [0.49-1.50],0.5952167690356811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,24243,117,1.87 [1.33-2.64],0.0003354436572474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,24442,119,1.65 [0.97-2.81],0.062437549963823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,24871,123,1.43 [0.88-2.32],0.1451287318290461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,24589,123,1.07 [0.66-1.71],0.7935658762160921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,20704,98,1.17 [0.96-1.43],0.1222315230492021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,20651,100,1.17 [0.86-1.58],0.3090175448678949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,21311,104,1.17 [0.61-2.23],0.6328734108735328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,20560,100,1.25 [1.08-1.44],0.0022231944625696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,20726,100,0.71 [0.42-1.20],0.203063430605424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,24459,123,1.58 [1.08-2.31],0.0196198404509477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,24589,123,1.55 [0.94-2.57],0.0877386222393643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,21317,104,0.87 [0.69-1.09],0.2192838255471489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,24568,123,1.09 [0.91-1.30],0.3393989604972725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,23987,116,1.20 [1.05-1.37],0.007928466779967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,24128,118,1.50 [1.33-1.69],6.607377495700934e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,24128,118,1.37 [1.15-1.63],0.0004239130331192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,24670,121,2.45 [1.72-3.49],7.902701394230918e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,24128,118,0.96 [0.73-1.25],0.7504146117585172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,24459,123,1.91 [1.59-2.30],4.0901461305294335e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,24879,125,2.65 [2.01-3.50],7.16890817171857e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,24128,118,2.63 [1.86-3.72],4.815862314152208e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,20704,98,1.30 [0.86-1.96],0.2132533589270457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,24128,118,1.05 [0.77-1.42],0.7650394514836831
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,24232,118,0.90 [0.45-1.82],0.7714019565676382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,20657,98,0.77 [0.40-1.49],0.433777276725333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,24568,123,1.48 [0.93-2.33],0.094910671143784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,24128,118,2.87 [1.84-4.48],3.3512069843022647e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,24879,125,1.45 [1.07-1.96],0.0155350913258377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,24085,118,1.20 [0.86-1.67],0.2916318114288918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,24128,118,1.08 [0.85-1.36],0.5262687796455254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,24128,118,1.28 [0.85-1.94],0.2406569685566496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,24128,118,1.02 [0.83-1.25],0.8571011481633014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,24565,119,1.06 [0.74-1.52],0.7499853318011216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,24252,123,1.38 [1.03-1.85],0.0312634987649925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,24459,121,1.92 [1.44-2.57],7.897641809784154e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,24632,120,3.18 [2.14-4.73],9.483661241165472e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,24879,125,2.10 [1.34-3.29],0.0011303781556094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,24266,122,0.98 [0.89-1.08],0.688209417577454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,23981,121,1.09 [0.87-1.36],0.4676300666612755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,24128,118,1.12 [0.87-1.46],0.3796569531387607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,24009,116,1.07 [0.80-1.41],0.6598421280283763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,24521,119,3.04 [1.71-5.39],0.0001487796544554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,24509,120,0.49 [0.22-1.08],0.0751326019676636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,24565,119,1.03 [0.71-1.49],0.8769743719825518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,24780,122,1.03 [0.73-1.44],0.8687316595248248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,24128,118,1.08 [0.71-1.63],0.7292441820109448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,24493,120,1.30 [1.02-1.67],0.0366450252785535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,24128,118,1.48 [0.87-2.52],0.1504897330532971
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,24128,118,0.99 [0.71-1.39],0.9650858000448652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,24128,118,1.10 [0.78-1.53],0.5923821775505795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,20704,98,1.08 [0.69-1.68],0.7423074569837225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,20704,98,1.15 [0.84-1.57],0.379452867098944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,21201,104,0.93 [0.69-1.24],0.6008383314851699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,24128,118,1.24 [0.91-1.69],0.1751796112781638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,24128,118,1.04 [0.74-1.45],0.827655065695014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,20484,100,0.59 [0.34-1.02],0.0607619209021469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,24408,121,3.30 [2.56-4.25],3.5041857626635336e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,24128,118,1.06 [0.70-1.61],0.7718081570389135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,21201,104,1.54 [1.13-2.10],0.0062553749069695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,20560,100,1.18 [0.84-1.65],0.3454213869096689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,20704,98,0.85 [0.58-1.25],0.406256770881954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,20633,97,1.04 [0.64-1.69],0.8724502177876817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,24568,123,1.68 [1.22-2.30],0.0013637657071817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,24128,118,1.70 [1.16-2.49],0.0067856781893384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,23962,120,1.15 [0.72-1.83],0.5587546319264785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,20704,98,1.04 [0.76-1.43],0.7957169054291232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,20639,98,0.90 [0.66-1.23],0.5013340374358951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,24128,118,1.61 [0.99-2.60],0.0530467371215007
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,24128,118,1.02 [0.85-1.23],0.8322383230595471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,24568,123,2.01 [1.37-2.94],0.0003418447101592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,24128,118,1.04 [0.93-1.16],0.5207665880674495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,24568,123,1.27 [0.95-1.69],0.1047423871756072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,24459,123,1.21 [1.01-1.45],0.0337582122748202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,24394,119,0.91 [0.57-1.45],0.6817012905439863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,24589,123,0.89 [0.36-2.22],0.807848243922418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,24568,123,0.94 [0.74-1.21],0.6503164951979024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,24565,119,0.86 [0.63-1.16],0.3238470838863077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,20915,101,1.19 [0.90-1.59],0.2246130277160453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23964,120,1.24 [0.97-1.59],0.088767831496848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,21201,104,1.61 [1.21-2.14],0.0010380788535592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,24421,122,1.05 [0.81-1.37],0.6906915264661205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,21260,104,1.31 [0.94-1.82],0.108078129268963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,20657,98,1.26 [0.72-2.19],0.4205388251981804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,23952,120,1.31 [0.99-1.73],0.062274468588884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,20839,104,1.20 [0.83-1.73],0.3306100521083741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,24565,119,0.90 [0.61-1.32],0.5835655666093995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,24459,123,1.32 [1.00-1.74],0.0460435061984888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20726,100,1.35 [0.99-1.85],0.0590266885496221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",21284,104,1.14 [0.76-1.73],0.5239595355137466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",24459,123,1.06 [0.90-1.25],0.4689836654892788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,21260,104,0.75 [0.60-0.95],0.0144469060407106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,21201,104,0.87 [0.58-1.32],0.5115969913457503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,21226,105,1.11 [0.93-1.34],0.2514484443383706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,20704,98,1.30 [0.41-4.15],0.6525204387148964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,24380,122,1.07 [0.90-1.28],0.4377374460207868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,24459,123,1.40 [1.07-1.82],0.0141013659261386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",24142,117,1.25 [1.06-1.46],0.0065613434978828
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,24128,118,1.09 [0.87-1.37],0.4471598825353572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,24568,123,0.98 [0.84-1.14],0.8006918113825124
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,23632,119,0.88 [0.57-1.36],0.5688424767439701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,24568,123,0.84 [0.56-1.25],0.3973345860245857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,21308,103,0.98 [0.64-1.50],0.9261444740273168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,21075,105,1.02 [0.84-1.23],0.8615227125470759
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,24568,123,0.77 [0.48-1.23],0.2760393841808864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,20839,104,0.74 [0.43-1.30],0.297711820259081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,24565,119,1.43 [0.75-2.70],0.2734903788186792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,24568,123,0.62 [0.44-0.87],0.0056214949815036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,20704,98,1.66 [1.05-2.64],0.0306058756212293
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,24565,119,1.00 [0.60-1.66],0.9993655362847405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,24795,121,0.57 [0.22-1.46],0.2408148898828332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,20915,101,1.22 [0.88-1.68],0.2261241329264154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,24509,119,0.91 [0.43-1.93],0.7986118173671817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,23987,116,1.20 [0.81-1.80],0.36648787230289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,24142,117,1.03 [0.89-1.19],0.7226081759873042
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,24417,119,1.92 [1.17-3.13],0.0092197535254179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,24624,121,0.78 [0.51-1.20],0.2632485663705125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,24128,118,1.31 [0.75-2.27],0.3386665156975967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,24795,121,1.22 [0.87-1.71],0.243698053875414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,21308,103,1.63 [1.01-2.63],0.0444934435275292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,21343,105,1.11 [0.43-2.90],0.8244926229710734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,24632,120,1.08 [0.71-1.64],0.7199112860429541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,21343,105,1.29 [0.67-2.49],0.4537857909614911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,21201,104,1.17 [0.80-1.73],0.4122946727894282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,24568,123,1.53 [1.19-1.96],0.0009350197165902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,20651,100,1.23 [0.94-1.61],0.1296251407785645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",20726,100,1.16 [0.91-1.48],0.2264051957871123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",20657,98,1.01 [0.67-1.52],0.9560262147638846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23999,120,1.45 [1.12-1.87],0.004772572378117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,20560,100,1.06 [0.74-1.53],0.7326095853389434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,24812,122,2.23 [1.25-4.00],0.0069599426351808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,20839,104,1.24 [0.87-1.75],0.233296095770366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,24128,118,1.81 [1.42-2.31],1.372442860987499e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,20560,100,1.15 [0.84-1.57],0.371901569627406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,21226,105,1.06 [0.86-1.31],0.5922633376650159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,24128,118,1.32 [1.05-1.65],0.0170468986416704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,24459,123,1.39 [0.95-2.03],0.0852979274886291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,21226,105,1.10 [0.92-1.31],0.3043351582129113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,20657,98,0.99 [0.70-1.41],0.9735220142567078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,20725,96,1.06 [0.82-1.35],0.6633566811989913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,23999,120,1.05 [0.78-1.42],0.7401546575774386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,20840,99,1.65 [1.26-2.15],0.0002880922579161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,20704,98,1.18 [1.00-1.38],0.0494491120986457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,24624,121,0.71 [0.39-1.27],0.2421840396976218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,23999,120,1.21 [0.77-1.90],0.401925860685887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,20560,100,1.18 [0.94-1.49],0.1431677789419357
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,20726,100,1.31 [0.97-1.76],0.0734835703962379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,21260,104,1.64 [0.99-2.73],0.0545586854703772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,20915,101,0.88 [0.67-1.16],0.3605925977444778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,20915,101,0.87 [0.44-1.75],0.7011669149901416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,21201,104,1.42 [1.15-1.74],0.0008896169864143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,20651,100,1.26 [0.82-1.92],0.2906397466307338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,20657,98,1.07 [0.84-1.36],0.5884572129730037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,20651,100,1.05 [0.90-1.23],0.550286010551658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,24459,123,1.01 [0.83-1.22],0.95760066152754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,21201,104,1.24 [1.00-1.54],0.0512249844645402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23987,116,1.41 [1.15-1.74],0.0011154666592147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,21226,105,1.00 [0.89-1.11],0.9362234999263744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,23987,116,0.99 [0.87-1.14],0.9182791352310984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,20560,100,1.02 [0.81-1.27],0.8780094704721457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,20657,98,1.26 [1.00-1.58],0.051056937983277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,23999,120,1.57 [1.07-2.29],0.0202369300991619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,24603,120,0.55 [0.32-0.95],0.0305906850448823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,24589,123,0.97 [0.64-1.49],0.8966808305457583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,23999,120,1.21 [0.97-1.50],0.0849863565981317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,20657,98,1.28 [0.84-1.95],0.2476864366313528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,21284,104,0.93 [0.64-1.36],0.7111260324772831
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,24319,119,1.00 [0.88-1.14],0.9914541521965392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,24551,121,1.07 [0.72-1.60],0.7289023171291849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,24375,121,1.61 [0.99-2.61],0.0549568447351383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,23987,116,1.08 [0.96-1.22],0.2095623742256948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,24005,121,1.35 [0.94-1.94],0.1053869410476326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,24795,121,1.12 [0.79-1.58],0.5252211808788549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,21168,104,1.23 [0.85-1.78],0.2731121318940667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,21308,103,1.10 [0.88-1.39],0.3946465505879516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,24795,121,1.37 [1.08-1.73],0.0081553672388898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,24588,120,0.95 [0.55-1.62],0.842211744649352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,20290,100,0.77 [0.46-1.27],0.3077801143301719
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,23722,118,1.16 [0.73-1.84],0.5307663859223648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,20936,100,0.88 [0.41-1.85],0.7293423428918465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,24879,125,2.28 [1.53-3.40],5.646236192975923e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,20657,98,0.96 [0.69-1.35],0.8326311588055623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,24879,125,1.96 [1.41-2.72],6.554089359090288e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,20704,98,1.16 [0.79-1.70],0.4498264756030922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,21260,104,2.00 [1.47-2.73],1.0819659443971755e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",23241,115,1.04 [0.59-1.82],0.9021660607354108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",20651,100,0.81 [0.47-1.37],0.4239742289404309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",24459,123,1.19 [1.00-1.43],0.0496331029152723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",24539,123,1.47 [1.19-1.83],0.0004659824105226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",23999,120,1.26 [0.93-1.71],0.1337371712690481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",20651,100,1.36 [0.95-1.95],0.0888965337109568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",20657,98,1.00 [0.76-1.32],0.995948766611943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,24539,123,1.11 [0.84-1.46],0.4535755319796262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,24879,125,1.26 [0.91-1.76],0.1634767302932266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,24624,121,1.35 [0.78-2.34],0.2904363648721387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,21317,104,1.03 [0.84-1.27],0.790373684668942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,21164,104,1.34 [0.99-1.83],0.0582357833531438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,24589,123,0.99 [0.78-1.26],0.9668877365796698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,24459,123,2.12 [1.71-2.62],8.204492943435093e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24550,121,2.04 [1.53-2.73],1.4663633615768015e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,24421,122,1.30 [1.10-1.53],0.0016704325666891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,20651,100,1.20 [0.90-1.60],0.2055773005956533
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,24670,121,0.86 [0.54-1.39],0.55004820693854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,20726,100,1.85 [0.98-3.48],0.0562219155749479
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,20733,101,1.11 [0.60-2.04],0.7454960177344535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,23835,117,1.12 [0.48-2.62],0.7897814541371726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,24830,124,1.57 [1.17-2.10],0.0027520202747369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,21201,104,1.59 [1.16-2.20],0.0043404712746167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,24128,118,1.20 [0.87-1.66],0.2627359417941747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,21201,104,1.15 [0.89-1.49],0.2876430715170391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,24879,125,0.93 [0.76-1.14],0.4800224377913916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,24459,123,1.00 [0.89-1.14],0.9489595666966136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,20704,98,1.00 [0.80-1.25],0.9963858568361958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,24374,122,2.53 [1.66-3.85],1.438825048096388e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,24632,120,1.26 [0.96-1.65],0.0915475190478406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,24812,122,1.26 [1.05-1.52],0.0142728220706803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,21324,106,1.08 [0.46-2.51],0.8653431494116713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,21284,104,1.23 [0.96-1.58],0.0974709541475898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,23790,116,1.42 [0.95-2.14],0.0894996595904792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,21308,103,1.51 [1.07-2.13],0.0181098051639493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,24634,122,1.06 [0.78-1.43],0.7096256288812979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,21284,104,1.03 [0.85-1.24],0.7738203557892087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,21317,104,1.24 [0.95-1.62],0.1112216751552689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,24763,121,1.01 [0.74-1.36],0.9698913135615485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,20096,101,1.20 [0.92-1.56],0.173334421990938
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,20657,98,0.98 [0.75-1.29],0.9000960051765559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,21284,104,1.00 [0.53-1.90],0.9935187350507612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEP,Leptin,24589,123,0.99 [0.79-1.25],0.948116920421306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,24589,123,0.95 [0.57-1.60],0.8536813109444574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,21284,104,1.63 [1.22-2.16],0.000801277948542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,24589,123,1.77 [1.15-2.73],0.0096451635679955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,24630,121,2.49 [1.57-3.94],0.0001005818052863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,21343,105,1.51 [0.92-2.46],0.1000416612446774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,24550,121,1.40 [1.05-1.86],0.0198760784298629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,24541,121,1.25 [0.87-1.80],0.2352051108283275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,24812,122,1.21 [0.94-1.56],0.138934425910141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,24546,120,4.73 [3.16-7.07],3.517573631332925e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,24670,121,1.21 [0.79-1.87],0.3819794387951269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,23987,116,1.02 [0.85-1.22],0.851208878424336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,24582,121,1.19 [0.92-1.54],0.1912955636789045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,23999,120,1.47 [1.20-1.80],0.0002491448743161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,24568,123,1.52 [0.82-2.82],0.1852342217582837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,24565,119,2.23 [1.39-3.60],0.0009781636019674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,21308,103,1.11 [0.93-1.32],0.2318383539496268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,20651,100,1.25 [0.91-1.72],0.1615295753788189
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,24561,123,2.22 [1.39-3.57],0.0008966946081031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,21317,104,1.17 [0.91-1.50],0.229670889774925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24871,123,2.80 [1.59-4.93],0.0003538199223574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24733,122,2.12 [1.33-3.39],0.0017083176356809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,24128,118,2.53 [1.79-3.58],1.6338049157460805e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,24871,123,1.17 [0.92-1.48],0.2033110691190866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,20726,100,0.84 [0.60-1.16],0.2871992060090645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,21181,105,1.37 [1.10-1.70],0.0044907923667592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,21260,104,3.37 [2.32-4.89],1.7254491593695798e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,21284,104,1.30 [0.82-2.06],0.2573864847586103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,20657,98,0.91 [0.65-1.26],0.5540514123929263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",20726,100,1.17 [0.94-1.44],0.1531505179397927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),20826,101,1.10 [0.99-1.23],0.0776653112638307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,24459,123,1.26 [0.97-1.63],0.0831783254419572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,24589,123,1.22 [0.87-1.71],0.2448046105354122
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,23804,120,1.28 [0.98-1.66],0.0649932217846514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,20651,100,1.17 [0.88-1.55],0.2766149635417356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,20651,100,1.28 [0.99-1.64],0.0551032689181991
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,20725,96,0.81 [0.51-1.30],0.3896097518896682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,21343,105,3.20 [1.88-5.44],1.675236322524874e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,24732,121,3.00 [1.99-4.51],1.3245672018660813e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,20633,98,1.41 [0.81-2.48],0.22498358255026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,24459,123,1.42 [0.80-2.53],0.2336618113802077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,24589,123,1.54 [0.99-2.40],0.0532873885895605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,20725,96,1.30 [0.82-2.08],0.2653924597134615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,20725,96,1.23 [1.03-1.48],0.0257382082595436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,24812,122,1.12 [0.86-1.45],0.3990585526057962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,24459,123,1.65 [1.18-2.31],0.0034039158524649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,21226,105,1.61 [1.04-2.49],0.032081786233388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,20725,96,1.12 [0.76-1.65],0.5797790331996945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,21317,104,1.33 [0.93-1.90],0.1177400233517689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,21201,104,1.26 [0.88-1.80],0.1985205314487267
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,24128,118,0.76 [0.50-1.16],0.2032281410011269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,20725,96,1.47 [1.04-2.08],0.0295690448993216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,21284,104,1.22 [0.62-2.40],0.5578595424297489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,23987,116,0.96 [0.71-1.31],0.8177586931629741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,20915,101,1.01 [0.81-1.26],0.9288627629394898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,24568,123,1.47 [1.02-2.12],0.0392094381650958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,24568,123,2.28 [1.73-2.99],3.2740393967520363e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,24795,121,1.05 [0.81-1.37],0.7013423154601182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,21201,104,1.17 [0.72-1.92],0.5261548693832145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,24871,123,2.80 [1.76-4.47],1.4783030558574782e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,23987,116,1.45 [1.17-1.80],0.0007035108725068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,24410,120,3.52 [2.17-5.71],3.5512289865916945e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,24128,118,0.88 [0.57-1.34],0.5375654563479827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,21201,104,1.40 [0.99-1.98],0.055201620924489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LXN,Latexin,24302,120,1.09 [0.87-1.37],0.4587013903081266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,24408,119,1.94 [1.37-2.73],0.0001606101970297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,24568,123,1.64 [1.06-2.52],0.0253105243263263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,24340,121,6.57 [4.25-10.16],2.4507284072399898e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,24421,122,1.82 [1.27-2.62],0.0011173017877744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,23987,116,1.27 [1.02-1.58],0.0324061460295649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,24459,123,0.92 [0.76-1.11],0.3700887561452388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,23999,120,1.01 [0.78-1.29],0.9659496565261472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,24439,121,0.78 [0.49-1.26],0.313934881825572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,23987,116,1.46 [1.17-1.82],0.0008466675985621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,20657,98,1.01 [0.85-1.21],0.8885242252608926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,20725,96,1.15 [0.98-1.36],0.0865218016967069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,21343,105,0.63 [0.24-1.64],0.3413348538921346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,20560,100,0.45 [0.24-0.85],0.0135640436059651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,20839,104,1.01 [0.78-1.31],0.9338575651942408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,20726,100,1.57 [1.14-2.17],0.0060225027565659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,24343,122,1.60 [1.33-1.91],3.582496263231413e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,23987,116,1.08 [0.72-1.61],0.7220463973751282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,20725,96,0.98 [0.64-1.49],0.9305125446574228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,20915,101,0.97 [0.78-1.22],0.8178015760321438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,23987,116,1.21 [0.88-1.68],0.2413074038489135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,21317,104,1.48 [0.86-2.56],0.1598505324834682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,21201,104,0.71 [0.50-1.00],0.0496193266809326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20726,100,3.70 [1.79-7.64],0.0004121076755853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,21317,104,1.00 [0.73-1.37],0.9884226357865455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",20560,100,0.94 [0.64-1.37],0.7378428611862968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,24670,121,1.01 [0.89-1.16],0.8370953406801545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,24624,121,1.50 [0.84-2.67],0.1689960884036649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,20651,100,1.19 [0.90-1.59],0.2224805495594522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,20657,98,0.79 [0.43-1.46],0.4505634903988802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,20651,100,1.17 [0.92-1.49],0.197469612612685
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,21260,104,1.28 [0.88-1.85],0.1925667623139611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,21226,105,1.35 [1.03-1.78],0.0326467875596466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,24568,123,0.93 [0.80-1.09],0.3637530802736008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,23987,116,1.18 [1.01-1.38],0.0377043611784245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,24374,122,1.03 [0.89-1.19],0.6762229422095543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,20560,100,1.24 [0.87-1.78],0.2354325794803618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,24568,123,1.10 [0.76-1.57],0.6210842014141429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,20915,101,1.15 [0.89-1.48],0.2829613155003065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,20560,100,1.13 [1.01-1.26],0.0270544892223774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,23999,120,1.19 [0.86-1.65],0.2882682368787195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,24589,123,4.21 [2.30-7.71],3.254670844634581e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",20792,103,1.09 [0.88-1.36],0.4312246450892342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,24374,122,1.03 [0.52-2.02],0.9364121516355496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,24594,121,2.27 [1.34-3.85],0.0023622430187866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,24380,122,0.90 [0.54-1.48],0.6680328907250465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,23987,116,1.12 [0.94-1.34],0.1912327294649785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAX,Protein max,23999,120,1.02 [0.88-1.19],0.7713194459650362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,24871,123,1.49 [1.16-1.91],0.0016288056035833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,21040,101,1.14 [0.95-1.36],0.1617906765674703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,24632,120,0.85 [0.52-1.38],0.5012070663577782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",21284,104,0.98 [0.63-1.52],0.9297056326357024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,20704,98,1.00 [0.81-1.24],0.9665895767559288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,24480,122,1.10 [0.77-1.56],0.5986228472220276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,21226,105,0.75 [0.34-1.64],0.4662185884463472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,24421,122,1.30 [1.03-1.64],0.0246351018616376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",21201,106,1.39 [0.91-2.11],0.125485457954484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDK,Midkine,24544,121,1.07 [0.79-1.45],0.6772585529087078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,20725,96,1.25 [0.68-2.29],0.4704656862571188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",20726,100,1.17 [0.96-1.44],0.1208215881314158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,23987,116,1.03 [0.83-1.28],0.7618712899595568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,20651,100,1.07 [0.74-1.53],0.7291634428851137
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,24550,121,1.04 [0.70-1.55],0.8460462553242686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,20651,100,1.03 [0.57-1.87],0.9194524219285836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,24780,122,0.98 [0.46-2.10],0.9641736451968768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,21317,104,1.23 [0.65-2.33],0.5187214543106928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,20839,104,0.64 [0.28-1.47],0.2952756949045265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,21226,105,0.81 [0.62-1.05],0.1153200683185171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,24589,123,1.03 [0.89-1.18],0.723881556545696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,24550,121,1.17 [0.60-2.27],0.63806954450957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,24879,125,2.25 [1.24-4.09],0.0075000606555484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,24565,119,1.02 [0.89-1.16],0.7931818457201429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,24627,122,1.09 [0.49-2.45],0.8319078990655102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,23999,120,1.39 [0.87-2.22],0.1651704121133965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",24568,123,0.97 [0.80-1.18],0.7772976067805122
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,24763,121,1.02 [0.77-1.34],0.8935488593743061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,24142,117,0.91 [0.64-1.30],0.5986232634258284
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,20725,96,0.85 [0.60-1.21],0.3704368503834691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,20839,104,1.53 [0.86-2.75],0.1511367330694847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,24871,123,1.05 [0.71-1.56],0.8016751993101245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,24565,119,1.08 [0.75-1.54],0.6773624036890658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,24635,121,0.97 [0.81-1.16],0.7656338746552889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,24568,123,0.96 [0.84-1.09],0.5188196710526721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,24624,121,1.41 [0.92-2.14],0.112450486319138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,20725,96,1.14 [0.88-1.48],0.3316591918803758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,24568,123,1.05 [0.94-1.18],0.3667416281736581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,24522,119,1.08 [0.85-1.37],0.5167181683437347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,24128,118,1.64 [1.22-2.20],0.0010589671769515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,21201,104,1.07 [0.90-1.27],0.4700658592190935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,21260,104,1.07 [0.88-1.31],0.486111147956092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,24421,122,1.05 [0.89-1.24],0.5626878441054134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,20704,98,1.59 [1.23-2.05],0.0003809141390278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,20560,100,0.99 [0.75-1.30],0.9329115188068582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,24568,123,1.05 [0.88-1.25],0.5706390890443892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,24459,123,1.01 [0.83-1.23],0.9292057846724556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,23709,121,1.06 [0.88-1.26],0.5447242900033684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,24527,121,1.17 [0.90-1.53],0.2453388897119064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,24619,121,1.64 [1.23-2.18],0.0008326161648094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,23999,120,1.35 [0.81-2.24],0.2529350312542939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,21317,104,1.16 [0.85-1.57],0.344578652657687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,24565,119,1.09 [0.78-1.53],0.615626248828802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,24103,117,1.38 [0.97-1.95],0.0729052213220481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,24773,121,1.02 [0.82-1.27],0.8576032726930298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,24532,119,0.95 [0.73-1.24],0.7204587040699671
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",20651,100,0.97 [0.66-1.42],0.862893488888659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,20725,96,1.23 [0.94-1.63],0.1372053215062941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,20915,101,1.13 [0.77-1.65],0.5450590824952126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,24553,122,1.08 [0.93-1.25],0.3202239538347124
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,20839,104,1.16 [0.89-1.53],0.2742281925890476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,24795,121,1.02 [0.62-1.68],0.9344874839795684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,21260,104,1.84 [1.19-2.86],0.0063878779156456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,20915,101,0.72 [0.41-1.24],0.2319122877311446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,20560,100,1.26 [0.81-1.98],0.3081698244367349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,20560,100,0.94 [0.73-1.21],0.6245943666212106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,24142,117,1.08 [0.88-1.34],0.4503411739674788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,24459,123,1.09 [0.91-1.31],0.3416468184096269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,24635,121,0.99 [0.81-1.22],0.942631875408489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,24565,119,1.59 [1.19-2.12],0.001679317587823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,21166,104,0.80 [0.52-1.23],0.3168191136954008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,21324,106,1.95 [1.04-3.68],0.0380887904798053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,20725,96,1.42 [1.06-1.91],0.0204343509891035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",20651,100,1.32 [0.94-1.86],0.1133289168309574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",21284,104,0.87 [0.48-1.57],0.6423387479860225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",23999,120,1.23 [0.71-2.15],0.4652920701959628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",20524,100,1.35 [0.66-2.75],0.4057555456322478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",21284,104,1.15 [0.91-1.45],0.2321482452048549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",20704,98,1.15 [0.64-2.08],0.644923068341682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,24428,123,1.28 [0.97-1.69],0.0769503843343682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,20725,96,1.69 [1.12-2.55],0.0124826351919061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,24501,123,1.14 [0.90-1.44],0.2924904210381898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,24812,122,1.24 [0.88-1.76],0.2213660690408645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,24624,121,1.03 [0.83-1.28],0.7998016889662406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,21014,102,0.90 [0.71-1.16],0.4262528270928686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,24142,117,0.96 [0.71-1.32],0.8185336925960015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,20704,98,1.29 [1.05-1.58],0.0160416295436609
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",21260,104,1.90 [1.17-3.09],0.0097264424812088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,20915,101,1.09 [0.92-1.28],0.3163281259761341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",21226,105,1.03 [0.83-1.27],0.7911205663901983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,24142,117,1.29 [0.85-1.94],0.2346410292642174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,20651,100,0.88 [0.63-1.23],0.4636728746403805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,21226,105,1.09 [0.93-1.29],0.2855716345289416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,21201,104,1.09 [0.90-1.31],0.38220173435461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,20915,101,1.08 [0.78-1.50],0.623054655371821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,23999,120,1.21 [0.88-1.66],0.2352239985611157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,24459,123,1.06 [0.97-1.16],0.2210416824164654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,21308,103,0.86 [0.70-1.06],0.1498116498746422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,20560,100,0.98 [0.63-1.53],0.9439003207836868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,24128,118,1.17 [0.96-1.42],0.1121591511061044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,20839,104,1.15 [0.62-2.12],0.6633793041965819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",21317,104,1.25 [0.99-1.59],0.0644654205626523
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",20726,100,1.05 [0.85-1.30],0.6432742262347046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,21284,104,0.95 [0.71-1.27],0.7299623874373795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,21317,104,1.06 [0.88-1.27],0.5230749747959655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,20651,100,1.00 [0.66-1.52],0.9990135092763496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,20560,100,0.54 [0.31-0.95],0.0323360829277219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,21308,103,0.97 [0.82-1.15],0.754776234684035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",20651,100,0.90 [0.54-1.48],0.6658619607140551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,20726,100,1.29 [1.01-1.64],0.0390370533278092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,20726,100,1.22 [0.88-1.69],0.24045712274375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,20725,96,1.15 [0.96-1.38],0.1373041045629486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",20725,96,1.26 [0.91-1.75],0.158347614576556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,21284,104,1.43 [1.04-1.98],0.0280819300262015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,24128,118,1.06 [0.84-1.35],0.6071962953352299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,24565,119,0.99 [0.70-1.41],0.950767830917524
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,20657,98,1.16 [0.81-1.66],0.4070682131450324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,20651,100,1.03 [0.71-1.47],0.8924055910224394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,20839,104,1.12 [0.93-1.36],0.2340302056165737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,24629,121,1.49 [1.11-2.02],0.0090638237000652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,23987,116,1.24 [0.94-1.64],0.1319798109331789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,20651,100,1.19 [0.82-1.73],0.3585359316778751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,20725,96,1.06 [0.91-1.25],0.4464861840094926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,24310,121,1.34 [1.05-1.72],0.0195070504236071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,21201,104,1.34 [0.99-1.80],0.0553302822775207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,24589,123,1.21 [0.94-1.55],0.1365087791780068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,20670,98,1.42 [1.16-1.74],0.0007411518795874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,20687,99,1.58 [1.17-2.14],0.002938727335282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,20839,104,0.72 [0.31-1.69],0.4565854639379769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,23987,116,1.29 [1.03-1.62],0.0258582166815122
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,21190,105,1.11 [0.71-1.76],0.6465033179584763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,21260,104,1.78 [1.13-2.81],0.0135340316841106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",21284,104,1.17 [0.79-1.75],0.4312815482986981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,24624,121,2.21 [1.21-4.01],0.0094822220436764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,24128,118,1.24 [0.98-1.57],0.0768511267521337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,24632,120,0.71 [0.42-1.20],0.2027711963056906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,24565,119,0.63 [0.35-1.16],0.1385045744247211
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,24812,122,1.15 [0.75-1.77],0.5281207883434066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,24527,123,1.06 [0.89-1.27],0.4853733818142306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,24670,121,0.99 [0.86-1.15],0.927457125735416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,24128,118,1.26 [1.02-1.57],0.0353070392335808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,24535,123,1.72 [1.11-2.65],0.0151665830827667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,21226,105,2.10 [1.28-3.46],0.0032746431501872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,24795,121,1.94 [1.10-3.42],0.0218377270658047
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,23999,120,1.33 [1.15-1.54],0.0001054840722451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,21201,104,0.92 [0.67-1.28],0.6319170196809523
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,20659,98,1.44 [0.87-2.38],0.160249993496289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,21226,105,1.01 [0.82-1.24],0.9140480546331928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",23987,116,1.17 [0.99-1.38],0.0624563952251705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,20651,100,1.05 [0.63-1.73],0.8642026566759585
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,20651,100,1.00 [0.74-1.33],0.9784888717374022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,20704,98,1.06 [0.59-1.90],0.8449987602878269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,24561,123,3.05 [1.87-4.95],6.874068311636254e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,24624,121,1.76 [1.08-2.87],0.023687378697588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,20704,98,0.95 [0.63-1.41],0.7838715448216067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,20704,98,1.65 [1.14-2.40],0.0085795095662901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,23922,120,1.75 [1.29-2.39],0.0003776890854418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,20915,101,0.87 [0.65-1.16],0.3474083311010683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,24624,121,0.93 [0.63-1.37],0.7243600361936056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,24670,121,2.07 [1.23-3.50],0.006478445401166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,21201,104,1.04 [0.89-1.22],0.6004123490477487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,21284,104,1.66 [0.87-3.20],0.1263281227432303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,21324,106,0.93 [0.71-1.22],0.6098377161793267
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,24879,125,2.65 [1.57-4.47],0.0002801595791865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,20704,98,1.14 [0.93-1.41],0.2161056240515401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",24568,123,1.04 [0.89-1.22],0.6261560141951921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",24128,118,0.95 [0.72-1.25],0.7046559737129179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,20726,100,1.23 [0.96-1.58],0.1022549078447829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,21284,104,1.03 [0.67-1.58],0.900408950696076
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,20651,100,1.22 [0.95-1.57],0.1221235016660772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,20915,101,1.01 [0.74-1.39],0.9373211856188431
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,23987,116,1.42 [1.04-1.93],0.0278700817781623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",21226,105,1.05 [0.88-1.25],0.6020538148767365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,20651,100,1.16 [0.88-1.52],0.2884175151110323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,20651,100,1.37 [0.94-2.00],0.097786130636899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,24421,122,0.95 [0.27-3.40],0.94054991790461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,21317,104,1.46 [0.90-2.36],0.1267262494734244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,21260,104,1.52 [0.73-3.18],0.2627755928197879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,20354,102,3.79 [2.07-6.95],1.62599008955896e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,24561,120,0.87 [0.57-1.33],0.5109171662748034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,24565,119,0.97 [0.78-1.20],0.7509411325403702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,23987,116,1.21 [0.96-1.53],0.1058351554301534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,20726,100,1.25 [0.81-1.92],0.3073477877762116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,21239,103,1.29 [1.01-1.66],0.0413709599347202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,20725,96,0.89 [0.64-1.24],0.4879516313316048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,20657,98,1.09 [0.73-1.61],0.6832722139870264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,20704,98,1.76 [0.78-3.98],0.1719448799129632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,24594,121,1.01 [0.51-2.00],0.972606399427645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,21114,104,1.44 [1.15-1.81],0.0015393489021608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,24421,122,1.16 [0.97-1.40],0.1053889596256543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,20560,100,1.06 [0.68-1.65],0.8012061951113473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,21284,104,1.24 [0.98-1.57],0.0709950686886169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,24565,119,1.02 [0.52-2.00],0.9538409401883876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,20651,100,1.01 [0.85-1.20],0.9164684043089628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",23999,120,1.74 [1.37-2.19],3.6128754665041776e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",20651,100,0.78 [0.47-1.31],0.3542558004424235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",23999,120,2.12 [1.85-2.42],3.8299384222295555e-28
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,24871,123,5.03 [2.04-12.40],0.0004425420763655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,21308,103,2.09 [0.96-4.53],0.0627915368191587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,24871,123,1.95 [1.25-3.04],0.0033046234188424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,20955,101,2.36 [1.63-3.41],5.282805512680337e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,24589,123,2.34 [1.59-3.42],1.3408354372373882e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,20704,98,1.06 [0.60-1.85],0.8437579392188826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,20704,98,0.95 [0.78-1.16],0.6408129059122926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,21317,104,1.47 [0.99-2.18],0.0571757115924999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,24142,117,1.17 [1.02-1.34],0.0235622722401717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,24568,123,1.19 [0.86-1.66],0.2915671077874235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,20651,100,0.83 [0.50-1.39],0.4749349550750827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,23987,116,1.19 [1.02-1.39],0.0253907892761087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,24565,119,0.65 [0.43-0.98],0.0391447766864091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,21308,103,0.74 [0.42-1.28],0.2797660383834565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,24589,123,1.21 [0.78-1.88],0.3954155245763268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,24795,121,0.91 [0.72-1.16],0.4445136652743189
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,24589,123,2.95 [1.76-4.97],4.479567709583645e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,21324,106,1.01 [0.83-1.23],0.917572928789604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,21284,104,1.09 [0.69-1.74],0.7018478650902442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,24685,120,1.27 [0.71-2.25],0.4172918985367838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,24565,119,1.33 [0.78-2.29],0.2961492684399203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,24128,118,1.34 [1.03-1.74],0.0270246351210763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,20725,96,0.92 [0.51-1.64],0.7666450210274662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,24812,122,1.06 [0.83-1.35],0.6376705694672722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",21317,104,1.20 [0.93-1.54],0.1534209842985664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,21260,104,1.73 [1.21-2.46],0.0023371266624399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,24525,123,0.97 [0.81-1.16],0.7452535882302801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,24624,121,1.01 [0.76-1.35],0.924938304898986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,24568,123,0.83 [0.52-1.32],0.4223621693081467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,23987,116,1.22 [0.86-1.73],0.2684101604587956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,24589,123,0.61 [0.32-1.13],0.1179365817509804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,24812,122,0.59 [0.29-1.23],0.1612681603779236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,24589,123,1.41 [1.22-1.63],3.4991364539894256e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,24568,123,1.09 [0.91-1.31],0.3435140931217829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,21201,104,1.12 [0.94-1.32],0.2035621247422805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,24760,121,1.35 [0.90-2.04],0.147726857056508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,24879,125,1.04 [0.81-1.33],0.7593697271360422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,20726,100,1.81 [1.21-2.70],0.003606466987328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,20651,100,1.47 [1.17-1.85],0.0008755509486103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,21193,104,1.01 [0.82-1.25],0.922853415577981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],24459,123,1.01 [0.77-1.33],0.9193461850138088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,24565,119,1.22 [0.90-1.66],0.2056839275636729
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,20704,98,1.09 [0.87-1.37],0.4621277002651125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,20651,100,1.82 [1.26-2.62],0.0012796465029228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,20651,100,0.96 [0.54-1.72],0.892016663818384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,23999,120,1.18 [0.79-1.77],0.4167632771793089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,20704,98,1.07 [0.56-2.04],0.8433206602076463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,24340,122,1.06 [0.82-1.37],0.6764293213725923
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,21284,104,2.01 [1.40-2.90],0.0001589660368851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,23962,120,0.97 [0.71-1.33],0.8632209097753338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,20915,101,1.30 [1.06-1.60],0.0117768764976526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,21226,105,1.08 [0.84-1.40],0.5420617994399402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,24459,123,2.34 [1.51-3.62],0.000134809484446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,24565,119,1.61 [1.09-2.39],0.0160757534567565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,20915,101,1.03 [0.77-1.38],0.8247733057568793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,20075,102,0.99 [0.85-1.16],0.9196515488216904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,24340,122,0.92 [0.70-1.20],0.542643568196876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,24670,121,0.91 [0.63-1.30],0.5934674079314516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,24459,123,0.89 [0.70-1.13],0.3277445129760083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,20657,98,1.11 [0.77-1.60],0.58651312237199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,21260,104,0.99 [0.84-1.18],0.938799436457722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,20726,100,1.30 [1.00-1.69],0.0481075668396969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,24459,123,0.95 [0.66-1.37],0.7731579146259601
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,21269,105,4.43 [2.07-9.44],0.0001194557743248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,21260,104,1.60 [1.22-2.11],0.0007946182711873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,24594,121,1.98 [1.22-3.21],0.0057792550766242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,24436,122,0.93 [0.75-1.16],0.5262524282933928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,24685,120,1.57 [0.71-3.44],0.2640277861624347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,20725,96,1.24 [0.86-1.79],0.2481950144352235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,20657,98,0.99 [0.68-1.44],0.9530915223926524
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,21226,105,1.30 [0.95-1.76],0.098826069747961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,21284,104,1.11 [0.83-1.48],0.4753943727681339
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",20726,100,1.43 [1.11-1.85],0.0060606297234264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,24812,122,0.92 [0.82-1.03],0.129781176703866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,24431,120,0.83 [0.55-1.25],0.3647686504402355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,20651,100,1.29 [0.96-1.73],0.0863771880300453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,24128,118,1.23 [0.99-1.52],0.060233558504218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,23962,120,1.18 [0.99-1.41],0.0580510662517075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,24421,122,1.12 [1.00-1.25],0.0469712749314781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,21284,104,1.13 [0.99-1.29],0.0606392468621246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",20915,101,0.97 [0.66-1.43],0.8751686498557432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,24142,117,1.23 [0.94-1.63],0.1332412984509189
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,20726,100,1.56 [1.14-2.15],0.0059563597238054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,20517,100,1.38 [1.02-1.86],0.0349702065550206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,23999,120,1.01 [0.78-1.31],0.9433579558690468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,20704,98,1.44 [1.00-2.06],0.0473502119118669
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,21111,105,1.62 [0.90-2.94],0.1090089078081535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,21260,104,1.61 [1.06-2.44],0.0264549883955703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,20651,100,1.14 [0.93-1.40],0.2215914585343543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,24744,123,1.59 [0.88-2.90],0.127457050393581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,24565,119,0.93 [0.52-1.67],0.8162131328799236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,24128,118,0.57 [0.40-0.80],0.0014011499725675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,20915,101,1.27 [1.03-1.55],0.0248371068046671
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,24565,119,1.09 [0.81-1.49],0.5605641394394301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,24568,123,1.27 [1.03-1.56],0.0232063989435325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,20839,104,1.55 [1.08-2.22],0.0172447635024305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,20560,100,1.28 [0.69-2.37],0.4319451989772751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,23999,120,0.89 [0.65-1.23],0.4874678516830046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,21226,105,1.43 [0.87-2.35],0.1566967169391154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,20657,98,1.17 [0.98-1.40],0.0752838802249546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20789,104,1.22 [0.85-1.76],0.2766626345318591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,21284,104,1.04 [0.81-1.34],0.7615690637752985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,24795,124,2.03 [1.18-3.49],0.010125674596971
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,21284,104,0.98 [0.47-2.04],0.9568722949173036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,24589,123,2.07 [1.36-3.14],0.0006969241970751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,21226,105,1.05 [0.62-1.77],0.8632535258296872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,21226,105,1.38 [0.79-2.40],0.2561212027628983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,21201,104,1.03 [0.65-1.63],0.9163609407641944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,20560,100,1.00 [0.75-1.33],0.9957500311360672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,21201,104,1.30 [0.91-1.86],0.1493763866522778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,24871,123,0.95 [0.64-1.42],0.8131480384937773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,21226,105,1.06 [0.84-1.36],0.6144370325693849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,21317,104,1.02 [0.84-1.23],0.8422300429275771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,24760,121,5.39 [4.45-6.54],9.699238304643684e-66
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,24459,123,1.86 [1.14-3.02],0.0126354224997194
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,24812,122,1.14 [0.88-1.49],0.3223362051929301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,24589,123,1.02 [0.81-1.28],0.8899654673038345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,20560,100,1.14 [0.83-1.57],0.4282063654201582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",20560,100,1.17 [0.88-1.56],0.2717977798612718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",20651,100,1.31 [1.05-1.63],0.0176533663338839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",20839,104,1.07 [0.89-1.28],0.4731487321529271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,24871,123,0.94 [0.76-1.16],0.56100720343993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,24670,121,0.95 [0.80-1.15],0.6180141039397589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,23987,116,1.45 [0.86-2.47],0.1662964714570453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,24589,123,1.55 [0.90-2.67],0.1133023771175413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,24871,123,1.39 [0.88-2.20],0.1604549093162141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,20560,100,0.78 [0.45-1.33],0.3550705561415607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,20839,104,1.74 [1.17-2.60],0.0063217443196165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,21308,103,1.17 [0.88-1.57],0.2841445003053953
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,20560,100,1.22 [0.94-1.58],0.1429284823991236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,21284,104,1.08 [0.92-1.26],0.3671770594845328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,24670,121,1.05 [0.93-1.19],0.4085225171013817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23987,116,1.34 [1.08-1.68],0.009190405667753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,20725,96,1.16 [0.84-1.59],0.3620233884194214
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,20560,100,1.01 [0.72-1.41],0.9596311450329956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,20651,100,1.30 [0.98-1.71],0.0660218623928205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,20704,98,1.46 [1.04-2.06],0.0292055040925274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,24871,123,0.77 [0.39-1.54],0.4595346121914105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,24565,119,1.17 [0.89-1.53],0.2495246053586793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,24565,119,1.46 [0.87-2.45],0.14985270350539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,20726,100,1.50 [0.88-2.56],0.1330704157522614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,20839,104,1.06 [0.56-1.99],0.8670683672285234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,21324,106,0.77 [0.38-1.55],0.4586800705510544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,20704,98,1.06 [0.90-1.24],0.4952709280830121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,21181,104,1.01 [0.83-1.22],0.9461067942080376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,23999,120,1.07 [0.80-1.42],0.6664260303370859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,20560,100,1.14 [0.84-1.54],0.4091991109329026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,20725,96,1.08 [0.82-1.41],0.6003545500288918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",24425,123,1.03 [0.84-1.27],0.7832957225559474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,21324,106,1.23 [0.92-1.65],0.1576362460766334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",21317,104,1.44 [1.05-1.98],0.0232457028875132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,24879,125,2.43 [1.81-3.26],3.303603668445255e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,24733,122,1.33 [0.93-1.90],0.1152106416366136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,21063,101,1.02 [0.55-1.91],0.9429800718187212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,20651,100,0.81 [0.56-1.17],0.2606172054809197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,20725,96,1.28 [1.01-1.61],0.0422082249560049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,20704,98,1.16 [1.01-1.34],0.0396777394589256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,21284,104,1.05 [0.89-1.23],0.560999533183903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,21226,105,1.49 [1.08-2.06],0.0165261443955798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,20560,100,1.11 [0.93-1.33],0.2530778957603472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,24421,122,1.85 [1.07-3.19],0.0265909096896271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,20839,104,1.34 [0.86-2.08],0.1993306042302705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,21324,106,0.92 [0.43-1.97],0.8347606632566664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PI3,Elafin,24227,119,1.03 [0.76-1.40],0.8246414130218677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",21284,104,1.15 [0.91-1.45],0.2514182941369268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,24262,117,1.44 [0.94-2.20],0.0910521874266239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24568,123,1.20 [0.93-1.53],0.1607071195920191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24565,119,2.75 [1.63-4.64],0.00014396196869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,20704,98,1.29 [0.98-1.69],0.0681435440696952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,24565,119,1.83 [1.23-2.70],0.0025908133119353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,24589,123,1.56 [1.15-2.12],0.0039698334358392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,20839,104,0.81 [0.62-1.06],0.1279638492481153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,20517,100,0.93 [0.72-1.21],0.58944820042256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,21317,104,1.56 [0.77-3.19],0.2185437452005561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,20651,100,1.48 [1.14-1.92],0.0028504672589241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,24584,121,1.16 [0.92-1.46],0.2211922644626057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,20915,101,0.97 [0.75-1.25],0.8024554607613981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,24421,122,1.10 [0.84-1.44],0.4916774557463746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,24624,121,1.61 [0.90-2.87],0.1068539229513135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,24828,123,1.06 [0.73-1.55],0.7603455328997973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",24511,120,1.07 [0.81-1.41],0.6192950225775709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,24670,121,1.04 [0.87-1.25],0.6470345247741998
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,24565,119,1.12 [0.67-1.90],0.6600935403189279
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,24780,122,0.79 [0.58-1.08],0.1423340635617974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,24565,119,1.48 [0.92-2.37],0.104763358828352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,24385,120,3.37 [1.96-5.78],1.014665199637439e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",21260,104,0.74 [0.55-1.00],0.0525323265248561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",20704,98,1.32 [0.95-1.83],0.1003443451154766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",21260,104,1.05 [0.87-1.27],0.6161856495363949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,21260,104,1.13 [0.87-1.47],0.3467793502631641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,20784,101,0.90 [0.39-2.10],0.8106129943635361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,23999,120,1.07 [0.68-1.68],0.7683940989394562
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,24589,123,1.33 [0.94-1.88],0.1035953343212977
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,24589,123,1.03 [0.82-1.30],0.7800733572187023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,21229,104,1.14 [0.84-1.56],0.3982642409149241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,24777,123,1.15 [0.74-1.79],0.528803639557952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,23987,116,1.38 [1.01-1.88],0.0421741325375201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,21260,104,0.75 [0.37-1.52],0.4220008385719439
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,24568,123,0.95 [0.78-1.15],0.587414823220612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,24753,122,3.51 [1.92-6.40],4.274905723663506e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,24507,121,0.93 [0.67-1.31],0.6846247796277818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,24495,123,1.04 [0.95-1.13],0.4069133000585205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,20651,100,1.08 [0.88-1.33],0.4485013085657539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,20651,100,1.24 [0.91-1.69],0.1670250434778381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,20725,96,1.22 [0.86-1.73],0.2755451155172118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,23961,120,1.00 [0.86-1.15],0.9616902475665148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,21324,106,1.08 [0.81-1.44],0.601624591876482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,21260,104,1.06 [0.84-1.35],0.607093495074605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,24550,121,1.03 [0.97-1.09],0.3365021880029373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,20726,100,1.14 [0.83-1.57],0.4078361500364161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,20657,98,0.89 [0.56-1.41],0.6207275401630361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",24128,118,0.99 [0.86-1.13],0.8341635381569308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,24459,123,0.49 [0.18-1.39],0.179785283234823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,24624,121,1.05 [0.59-1.87],0.8680563086609677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,20704,98,1.42 [1.01-2.00],0.0448669987187746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,20704,98,1.27 [0.71-2.28],0.4219782156738925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24459,123,1.74 [1.32-2.29],7.613390868889628e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,20726,100,0.87 [0.66-1.15],0.3272658234588008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,21324,106,0.52 [0.29-0.93],0.0287603135111129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,24142,117,1.55 [0.97-2.47],0.0642053463556219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,24670,121,1.05 [0.60-1.82],0.8724050668581089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,21308,103,0.81 [0.49-1.34],0.4125807785268849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,21171,102,1.03 [0.82-1.28],0.8051651131927314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,24812,122,1.11 [0.80-1.54],0.5486735090304007
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,24558,122,0.99 [0.84-1.16],0.865191276132742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,20915,101,1.02 [0.76-1.38],0.873372822378826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",21308,103,1.06 [0.80-1.42],0.6785624634786147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,20704,98,1.05 [0.59-1.88],0.8734228463527767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,23987,116,1.26 [0.79-2.00],0.3346655959904064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,20704,98,1.32 [1.07-1.63],0.0094048597496665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,21317,104,1.09 [0.77-1.54],0.6272808658053205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,24459,123,1.12 [0.86-1.45],0.4006326076567701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,21201,104,1.08 [0.87-1.34],0.4960076342039264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,24624,121,1.02 [0.86-1.20],0.8602436028148175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,20915,101,1.13 [0.89-1.42],0.3187636544084877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,21284,104,1.00 [0.79-1.27],0.985085546355169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,21284,104,1.80 [1.26-2.57],0.0011508398757085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,24589,123,1.02 [0.84-1.24],0.8686568583802785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,24879,125,1.08 [0.91-1.27],0.375726360067191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,21226,105,1.08 [0.93-1.26],0.3235037079333394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,24421,122,1.39 [0.96-2.02],0.0836982257388295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,20725,96,0.96 [0.73-1.25],0.7497818364699056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,24498,121,0.90 [0.77-1.06],0.1969702718447457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,23987,116,1.22 [0.96-1.55],0.1016892138878174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,20560,100,0.94 [0.44-2.01],0.8759013805442185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,21308,103,1.50 [0.93-2.42],0.0949864877115566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,21201,104,1.04 [0.71-1.52],0.8541623552740418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,24705,121,2.17 [1.38-3.41],0.0008058953894366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,23913,117,1.04 [0.87-1.25],0.658845640325056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,20981,105,1.17 [0.88-1.56],0.2743353757921262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",24128,118,1.18 [0.95-1.47],0.1259806086636265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",24879,125,0.94 [0.75-1.18],0.6066566005345928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,24795,121,1.09 [0.84-1.42],0.5042895472385425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,24128,118,1.42 [0.90-2.23],0.1310339932593164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,24550,121,2.17 [0.99-4.74],0.0516636468529548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,21308,103,1.15 [0.80-1.65],0.4390414806999254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,21308,103,0.78 [0.54-1.12],0.1747008824445083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,24128,118,1.28 [0.98-1.68],0.0686806838751102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,20725,96,1.23 [0.68-2.20],0.4935148184505841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,24589,123,1.00 [0.83-1.21],0.9711618439225927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,21220,104,1.15 [0.92-1.44],0.2311742096810826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,24128,118,0.90 [0.60-1.34],0.5989182982387642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,20651,100,1.13 [0.78-1.64],0.5112005372101502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,20839,104,0.99 [0.86-1.15],0.9373319858369475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23987,116,1.26 [0.99-1.59],0.0567655917355641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,24812,122,1.01 [0.82-1.25],0.924796705190606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,21260,104,1.03 [0.71-1.48],0.8879646058669084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,24603,120,0.71 [0.38-1.32],0.2745247553113945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,20651,100,0.96 [0.55-1.65],0.870680617734667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,24568,123,1.08 [0.84-1.40],0.5339042835926323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,21343,105,0.85 [0.40-1.83],0.6828563793288642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,20701,104,1.21 [0.94-1.56],0.1424388758201288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,20704,98,1.34 [0.96-1.87],0.0827725544317207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,20726,100,2.14 [1.34-3.41],0.0014429970603538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,24632,120,1.10 [0.82-1.49],0.5246330510356849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,20704,98,0.67 [0.36-1.26],0.2189046522803151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,24498,122,1.11 [0.75-1.63],0.6156100891592797
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,21260,104,0.72 [0.45-1.17],0.1874117430342143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,24459,120,1.29 [0.88-1.89],0.198873353420169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,23999,120,1.02 [0.88-1.18],0.7918151190612057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,24795,121,0.80 [0.42-1.53],0.4992754098299342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,23944,117,1.57 [1.22-2.03],0.0005537875344712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,20915,101,0.99 [0.51-1.92],0.9725680554498004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,21116,102,2.49 [1.67-3.71],7.68471446086594e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,21226,105,1.40 [0.98-2.00],0.0670837349953735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,21226,105,0.97 [0.91-1.05],0.463484605466896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,24421,122,1.09 [0.94-1.27],0.2694204850937926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,24568,123,1.20 [0.98-1.48],0.0797621076920613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,23987,116,1.08 [0.77-1.52],0.6512664250138431
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,20560,100,0.83 [0.43-1.59],0.575463225006112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,21284,104,1.67 [1.26-2.20],0.0003474936971239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,20725,96,1.09 [0.78-1.51],0.6213290961284585
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,24459,123,1.12 [0.85-1.47],0.4229803822689113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,24394,122,1.71 [1.13-2.58],0.011419595810127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,24309,122,2.15 [1.42-3.25],0.0002974432823976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,24568,123,1.37 [1.02-1.84],0.0388777782065766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,20704,98,1.34 [0.99-1.82],0.0549070037199172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,24568,123,1.03 [0.87-1.21],0.7712597008442114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,23987,116,0.97 [0.73-1.29],0.8404713568594506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,20068,103,0.97 [0.82-1.16],0.7602138388022903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",23999,120,1.74 [1.04-2.93],0.0353393335106791
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,24363,119,2.32 [1.50-3.58],0.0001521857500968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,20548,97,1.10 [0.78-1.56],0.5778264156197332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,21317,104,0.88 [0.70-1.11],0.2878023933774343
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,20725,96,0.88 [0.69-1.13],0.3273053114195494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,24568,123,1.09 [0.73-1.61],0.6750361490886985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,23999,120,1.93 [1.31-2.85],0.000885712630069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,24142,117,1.59 [1.19-2.12],0.0015873516555054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,20704,98,1.07 [0.74-1.53],0.7262499538107754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,24421,122,1.26 [1.03-1.52],0.0210503502625354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,24635,121,0.96 [0.81-1.14],0.6595152175999413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,20659,96,1.06 [0.65-1.71],0.8217641164289033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,21317,104,0.89 [0.48-1.66],0.7188017256800694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,21308,103,4.93 [2.72-8.95],1.5796993209083824e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,24871,123,1.89 [1.09-3.30],0.0243424883449421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,21226,105,1.21 [0.84-1.75],0.3088744290960301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,21226,105,1.76 [0.95-3.27],0.0741824914851863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,24522,123,2.23 [1.19-4.19],0.0122221007039117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,24331,122,1.36 [0.82-2.26],0.229392900380063
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,21260,104,1.06 [0.63-1.75],0.8356092030711691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,24871,123,1.24 [0.65-2.36],0.5093046153681164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,21317,104,1.05 [0.58-1.88],0.8826852593512189
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,20839,104,1.08 [0.79-1.47],0.6402087225951552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,23891,120,1.19 [0.91-1.57],0.2062569936831773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,20915,101,1.44 [1.02-2.03],0.0356543038568027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,24568,123,1.20 [0.86-1.68],0.2821821741108243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,24701,121,0.99 [0.86-1.13],0.8814393697891187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,24812,122,0.70 [0.45-1.08],0.1062917030308935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,21201,104,1.08 [0.81-1.44],0.6016224422090217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,23999,120,1.54 [1.24-1.91],0.0001053933034688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,20726,100,1.22 [0.80-1.84],0.3588152788095472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,20651,100,0.96 [0.78-1.18],0.6850800659400423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,21343,105,1.31 [0.95-1.82],0.0992805845156737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,24470,122,1.15 [0.80-1.65],0.4572723059090012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,24569,120,3.18 [1.77-5.70],0.0001042221803598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,20899,102,1.28 [0.95-1.72],0.1098427002270471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,21317,104,1.05 [0.74-1.47],0.7931378330784177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,21317,104,1.02 [0.86-1.22],0.7929388979761374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,21317,104,1.03 [0.82-1.29],0.8307764750744833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,21201,104,1.05 [0.79-1.41],0.7258961877864221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,20651,100,1.17 [0.89-1.53],0.2669210501613496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,24128,118,0.99 [0.81-1.20],0.8891919816647942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,20651,100,1.16 [0.99-1.37],0.0653211592483321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,20657,98,1.14 [0.87-1.50],0.345353842653721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,21201,104,1.31 [1.01-1.70],0.0389268716636089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,24568,123,0.79 [0.55-1.12],0.1822074870903139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,23999,120,1.06 [0.76-1.47],0.7317126580300284
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,20839,104,1.09 [0.86-1.38],0.4962571144312893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,23987,116,0.99 [0.75-1.30],0.945561389098854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,24128,118,1.18 [0.91-1.52],0.2232833193747554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,20725,96,1.00 [0.75-1.33],0.9946641455627996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,23987,116,1.00 [0.70-1.43],0.994291415892904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,20915,101,0.97 [0.68-1.40],0.8896645506559738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,20704,98,0.97 [0.50-1.86],0.917354762020405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,21201,104,1.24 [0.92-1.67],0.1620389005279495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,20726,100,1.29 [0.90-1.83],0.1624841460518679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,20657,98,1.41 [0.84-2.38],0.1956173806006994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,23987,116,1.18 [0.89-1.57],0.2519848494567009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,20704,98,0.97 [0.72-1.30],0.8249498121686172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,20915,101,1.01 [0.71-1.44],0.9666408220858588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,23987,116,1.25 [0.84-1.87],0.2750571725442206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,24685,120,1.06 [0.76-1.47],0.744269639866195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,23999,120,1.03 [0.64-1.67],0.8954720496045787
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,20560,100,0.68 [0.43-1.10],0.1167318792571278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,23987,116,1.27 [1.03-1.57],0.0230507001385039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,21284,104,1.93 [1.44-2.58],9.41564046711094e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,24023,122,1.48 [1.10-1.99],0.0102760002211896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,21284,104,1.06 [0.83-1.35],0.6322646107064712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,20651,100,1.00 [0.66-1.51],0.9848105775633048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,20560,100,1.00 [0.66-1.53],0.9922570390160916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,20725,96,1.22 [0.99-1.50],0.0639420869362097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,24459,123,1.27 [1.04-1.55],0.0201271427231846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,24459,123,1.56 [1.22-1.99],0.0003212204952062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,21226,105,1.24 [0.96-1.60],0.1052814239878794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,20704,98,1.10 [0.85-1.42],0.4833942822578008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,20726,100,1.10 [0.91-1.32],0.3289248708055465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,21201,104,1.47 [1.17-1.83],0.0007319993356954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,24142,117,1.38 [1.09-1.75],0.007016103729623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,20726,100,1.49 [0.60-3.71],0.3926311235062402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,21284,104,1.22 [0.92-1.61],0.1631261014965432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,24414,119,1.30 [0.95-1.77],0.1008486129348403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,24871,123,1.19 [0.91-1.54],0.2043035850851476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,24871,123,1.43 [1.13-1.81],0.0027958558361495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,21201,104,0.80 [0.48-1.30],0.3633231798583034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,24594,121,1.54 [1.12-2.12],0.0079286279673841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,20704,98,1.18 [0.84-1.67],0.3362156379155586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,24565,119,3.46 [2.09-5.73],1.4880803757712585e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REN,Renin,24589,123,1.13 [0.90-1.40],0.2893003474060922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,20704,98,1.50 [0.98-2.28],0.0590152031751601
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,20560,100,0.63 [0.34-1.16],0.1392531761006137
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,24459,123,0.77 [0.51-1.16],0.2086195079517767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RETN,Resistin,24495,120,1.61 [1.16-2.22],0.004119591355906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",20651,100,0.58 [0.34-1.00],0.0486136612190131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,21201,104,2.24 [1.26-3.98],0.0061990811511413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,21284,104,1.05 [0.83-1.34],0.6759787184669623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,20915,101,0.93 [0.67-1.27],0.6353564634247895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,24812,122,1.08 [0.65-1.81],0.7574285823363487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,24812,122,2.00 [1.10-3.63],0.0232299888504513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,21284,104,1.03 [0.76-1.40],0.861964576204131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,24128,118,1.24 [1.02-1.50],0.0313727280732217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,24270,122,1.02 [0.89-1.17],0.7412696602951573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,20704,98,1.25 [0.90-1.73],0.1851608529976557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20839,104,1.14 [0.80-1.64],0.4706712949584095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,24732,121,1.08 [0.83-1.41],0.5560248054446373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,21317,104,1.03 [0.85-1.24],0.7811676508355134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,20651,100,0.96 [0.72-1.30],0.8105935742432557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,21284,104,0.94 [0.71-1.26],0.6974549907115657
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,20806,103,1.01 [0.86-1.18],0.9073015344388168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,21324,106,2.09 [1.09-3.99],0.025980077269114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,20726,100,1.33 [0.94-1.88],0.1087432485820126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,24462,121,1.04 [0.90-1.19],0.6017419443334813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,20638,106,1.72 [0.93-3.17],0.0817887089907845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,21170,106,2.07 [1.46-2.93],4.232966565314546e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,21284,104,1.37 [1.03-1.83],0.0329809749872968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,24749,121,3.10 [1.95-4.91],1.612987330609331e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,20726,100,3.41 [2.01-5.79],5.389742197751389e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,20704,98,1.53 [1.11-2.11],0.0095109893858803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,20704,98,1.46 [1.00-2.13],0.0473908237295299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,20915,101,0.82 [0.59-1.14],0.2355351399451735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,23987,116,1.28 [1.02-1.61],0.0311744481843618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,20915,101,1.10 [0.82-1.48],0.5118259011000712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,20726,100,1.09 [0.83-1.42],0.5360267095100453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,24594,121,3.64 [2.02-6.56],1.809466689885793e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,24812,122,1.35 [0.67-2.71],0.3945032574629331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,20726,100,2.74 [0.94-7.95],0.064357562761854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,24589,123,2.33 [1.41-3.84],0.0009800709910551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,24459,123,1.09 [0.76-1.56],0.6501213355298254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,20704,98,1.55 [0.93-2.57],0.0924101907454092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,20915,101,1.16 [0.91-1.49],0.235046384827064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,20725,96,1.63 [1.19-2.22],0.0021025408219734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,20726,100,1.51 [1.06-2.16],0.0227408197058097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,20651,100,1.24 [0.85-1.81],0.2742811239606575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,20725,96,1.09 [0.94-1.26],0.2613430422810324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,23987,116,1.64 [1.39-1.94],4.937562827413526e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23987,116,1.01 [0.79-1.28],0.9400040194662036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,20657,98,0.92 [0.74-1.14],0.4432616822525191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,24421,122,1.15 [0.74-1.80],0.5338967285157268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,24795,121,1.95 [1.13-3.37],0.0166375643777122
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,24459,123,0.88 [0.51-1.54],0.6642538419462536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,20651,100,1.02 [0.72-1.46],0.8944187116941438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",21284,104,1.05 [0.86-1.29],0.6091664319656145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,24795,121,1.26 [0.80-1.97],0.3196496212784452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,23987,116,0.99 [0.84-1.17],0.9263967080681056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,24812,122,1.10 [0.86-1.41],0.4418494841686737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,20651,100,0.97 [0.54-1.74],0.9118381568474214
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,24387,121,1.13 [0.84-1.53],0.4201495766862183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,24227,123,1.20 [0.97-1.48],0.0860357737043237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,20704,98,1.59 [0.99-2.56],0.0572113348744986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,21284,104,1.11 [0.79-1.57],0.5429674984824111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,23962,120,1.05 [0.81-1.35],0.7172137978773265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,21201,104,1.28 [0.95-1.74],0.1077980823459001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,24624,121,0.96 [0.72-1.27],0.7675167426989948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,21284,104,1.29 [0.89-1.88],0.1815945729525089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,24142,117,1.08 [0.82-1.44],0.5744514296021918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,21343,105,0.93 [0.49-1.77],0.8200270185554379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,21284,104,1.86 [1.16-2.98],0.0095808296343218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,20657,98,1.19 [0.86-1.64],0.2862950973921304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,24568,123,1.10 [0.89-1.36],0.3905377648057476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,20915,101,0.85 [0.64-1.14],0.2883223010069811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,21250,104,1.03 [0.87-1.22],0.7316045622679577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,20651,100,1.40 [1.02-1.93],0.035476969411552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,20651,100,1.15 [0.80-1.64],0.4471314476432355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,20915,101,1.00 [0.76-1.31],0.9817648625115084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,21284,104,1.15 [0.65-2.02],0.6322706965181288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,21269,102,0.98 [0.57-1.68],0.9284412892857056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,24459,123,1.07 [0.89-1.29],0.4493575205662581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,24812,122,0.93 [0.54-1.61],0.8005257235078446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,23999,120,1.05 [0.79-1.38],0.7473037107318292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,23950,118,3.15 [2.07-4.81],9.114142697598993e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,24871,123,1.30 [0.90-1.86],0.1603208061935488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,24812,122,2.10 [1.19-3.71],0.0105312368638432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,24697,121,0.82 [0.49-1.37],0.4457713584836759
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,24594,121,1.21 [0.74-1.97],0.4490031635397141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,24603,121,1.19 [0.89-1.60],0.2485633203869118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,20651,100,1.15 [0.65-2.02],0.634572080797182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,20839,104,2.16 [1.02-4.58],0.0446939048620432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,24635,121,1.11 [0.92-1.33],0.288957375024697
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,24128,118,1.35 [0.94-1.92],0.1008588850926552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,20657,98,0.86 [0.64-1.14],0.2865682654664906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,24732,121,1.02 [0.74-1.41],0.9022476127211856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,20657,98,1.06 [0.72-1.56],0.7721215604921452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,20725,96,0.90 [0.44-1.84],0.7736498177264548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,20725,96,0.91 [0.53-1.57],0.7343575180437019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,20657,98,1.31 [0.92-1.87],0.1303307350467779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,20726,100,1.38 [0.89-2.15],0.1485501182709663
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,23987,116,0.90 [0.71-1.13],0.3542218889112264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,20654,99,1.36 [0.95-1.95],0.0947985656169812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,21317,104,1.68 [0.94-2.99],0.0777894343909659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,20726,100,1.12 [0.93-1.36],0.2250255452659802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,24568,123,1.22 [0.93-1.59],0.1490728046816885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCT,Secretin,20725,96,1.09 [0.70-1.68],0.7134453573518554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,24589,123,2.10 [1.59-2.77],1.7511513055020532e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,24589,123,0.59 [0.42-0.82],0.0016726287787268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,21201,104,1.15 [0.98-1.35],0.0942979018055921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,21226,105,1.11 [0.86-1.42],0.4130204976531662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,20839,104,1.34 [0.82-2.18],0.2396259849334041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,20726,100,1.14 [0.89-1.47],0.3018635186172379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,20726,100,1.46 [1.02-2.10],0.038912442015875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,24871,123,1.28 [0.93-1.76],0.1318515586223256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,21343,105,0.77 [0.33-1.78],0.5382921750593902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,21343,105,2.82 [1.45-5.46],0.0021354578262248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,24632,120,0.87 [0.66-1.16],0.3519863377453019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,24568,123,0.81 [0.48-1.36],0.4272992048480104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,24589,123,2.46 [1.36-4.43],0.0028506260868778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,20839,104,1.70 [1.16-2.47],0.0058757951324459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,24459,123,1.27 [0.78-2.06],0.343416574649325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,24812,122,2.03 [1.19-3.47],0.0096252649778792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,20704,98,1.39 [0.75-2.57],0.2993166449034893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,24780,122,4.64 [3.23-6.67],1.0796055544772467e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,21284,104,0.85 [0.65-1.10],0.2175186784908287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,20915,101,1.43 [1.13-1.81],0.0029746718635003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,21212,104,2.05 [1.32-3.18],0.001464167331818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,24459,123,1.37 [0.83-2.24],0.2150628814459345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,20957,104,2.94 [0.37-23.06],0.3054527312073546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,24871,123,1.54 [1.04-2.27],0.0313855700267278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,23912,117,1.03 [0.91-1.17],0.6201077370112515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,21277,104,2.59 [0.96-6.97],0.0591363177598684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,20954,102,1.00 [0.45-2.24],0.9952332213901998
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,21029,102,0.53 [0.27-1.03],0.0623613840818753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,21343,105,0.62 [0.20-1.88],0.3953406347961885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,21343,105,2.19 [0.84-5.74],0.1093192262912402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,24337,123,1.84 [1.52-2.22],4.0425650161675804e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,24489,119,1.14 [0.96-1.36],0.1305850345404034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,24142,117,1.10 [0.78-1.55],0.5706849468080448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,24734,121,1.23 [0.95-1.60],0.120979821713295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,24879,125,1.42 [1.18-1.70],0.0001504337897252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,24421,122,1.52 [0.97-2.39],0.0709213495103936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,21298,102,2.83 [0.80-10.03],0.106547754616769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,21298,102,1.27 [0.65-2.46],0.4881116415908461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,24871,123,0.89 [0.71-1.12],0.3280274876809837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,21317,104,1.09 [0.82-1.44],0.5527261175258857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,21032,101,1.68 [0.86-3.28],0.131026908201098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,20947,101,1.09 [0.28-4.31],0.9034394536441088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,21298,102,2.77 [1.03-7.39],0.0425322869152254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,20915,101,1.00 [0.87-1.16],0.9714430205198108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,20792,103,0.85 [0.45-1.61],0.6240328655100607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,21226,105,1.06 [0.78-1.46],0.6931144777840603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23999,120,1.09 [0.85-1.40],0.486545470291294
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,24344,122,1.79 [1.12-2.85],0.0145138037653906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,20725,96,0.93 [0.49-1.77],0.8250729449310333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,24624,121,1.06 [0.59-1.91],0.8504076583403868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,24459,123,2.10 [1.13-3.90],0.018544852783356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,24459,123,1.00 [0.81-1.23],0.983607511075372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,24337,122,0.82 [0.56-1.20],0.3121533277102553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,20839,104,0.95 [0.60-1.49],0.8156639140921591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,23987,116,1.07 [0.82-1.40],0.617749672474364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,23987,116,1.31 [0.96-1.78],0.0840655410258479
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,24589,123,1.10 [0.86-1.39],0.4495187405204481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,20978,102,1.42 [1.07-1.88],0.0137343405251542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,23987,116,1.03 [0.87-1.22],0.7134386681510883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,24568,123,1.30 [1.05-1.62],0.0160460413755356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,20657,98,0.98 [0.71-1.36],0.9223747842146578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,21226,105,1.17 [0.84-1.62],0.3592021450641064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,20787,101,0.77 [0.63-0.93],0.0071846338994452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,21260,104,1.03 [0.78-1.36],0.8188046962855907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,21324,106,1.15 [0.80-1.65],0.4467424746761027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,20560,100,0.95 [0.80-1.13],0.5574588821506188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,20616,100,1.13 [0.93-1.37],0.2166422299283014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,20704,98,0.87 [0.54-1.38],0.5464456277245064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,21308,103,2.78 [1.81-4.28],3.274015633739586e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",24635,121,0.99 [0.82-1.19],0.895669997302438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,20915,101,1.11 [0.72-1.72],0.64291991945966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,24581,121,1.24 [0.89-1.72],0.2043002653694862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,24670,121,1.76 [1.24-2.50],0.0016191097245906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24568,123,5.51 [3.85-7.90],1.3087138580488023e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,23999,120,1.14 [0.96-1.37],0.1399882326398054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,24565,119,1.16 [0.99-1.36],0.073700588809567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,24795,121,2.72 [1.95-3.79],3.415312354390409e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,24589,123,1.36 [0.78-2.36],0.2820908180888495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,20726,100,1.91 [1.28-2.86],0.0016748166155249
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,24764,121,0.91 [0.54-1.52],0.7095525229929113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,20726,100,1.11 [0.66-1.88],0.6922928433753402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,24617,122,1.28 [0.95-1.73],0.106375491223654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,24499,121,2.28 [1.61-3.23],3.254286357770104e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,20704,98,1.20 [1.02-1.41],0.0252271828583643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,24459,123,1.04 [0.87-1.24],0.677450446274138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23999,120,0.86 [0.62-1.19],0.361828270803006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,24128,118,1.11 [0.83-1.49],0.4676557777450589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,24374,122,0.85 [0.68-1.06],0.1544354134468724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,24670,121,0.99 [0.85-1.15],0.8497177563221492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,20651,100,0.74 [0.43-1.28],0.2836565221248905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,21284,104,0.99 [0.83-1.18],0.918811642776169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,24128,118,1.20 [0.90-1.59],0.2199425354631456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,23987,116,2.15 [1.53-3.02],1.0008093870363203e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,24568,123,1.25 [0.96-1.64],0.1021532595402021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,23987,116,2.76 [2.05-3.71],2.456501162429913e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,20651,100,1.01 [0.50-2.01],0.9859438941389378
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,21201,104,0.97 [0.71-1.34],0.8567078553043832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,23999,120,1.02 [0.78-1.35],0.861823372150687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,20725,96,1.14 [0.82-1.60],0.4274164862845095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,23999,120,1.14 [0.92-1.42],0.2222115976278595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,20560,100,0.88 [0.61-1.25],0.467861091504425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,20560,100,0.94 [0.61-1.44],0.7759404426788347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,23999,120,1.50 [1.00-2.25],0.0474653872202198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,24568,123,1.14 [0.87-1.49],0.3441908038997792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,20725,96,1.09 [0.84-1.40],0.5309183604449362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,21308,103,1.23 [0.84-1.80],0.2847453343836323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,20651,100,0.87 [0.66-1.15],0.3389717086728201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20839,104,1.07 [0.86-1.33],0.5635967486057947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,21226,105,1.17 [0.87-1.57],0.3004760827800493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",20560,100,1.01 [0.73-1.41],0.9352020851049162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,23999,120,1.09 [0.80-1.47],0.5861523545993801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,20704,98,1.75 [1.00-3.07],0.0508691267150301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,24795,121,1.30 [0.87-1.96],0.203576916193015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,24142,117,1.81 [1.21-2.71],0.0039063136932203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,20915,101,1.12 [0.91-1.39],0.2715613661718779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,21226,105,1.19 [0.96-1.47],0.1098192398046075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,21157,102,1.33 [0.89-2.00],0.1624336242682917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,23987,116,1.07 [0.88-1.30],0.511965138106234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,21201,104,1.10 [0.85-1.43],0.4609266421030806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,21201,104,1.22 [0.86-1.73],0.270799649779386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,24459,123,0.54 [0.26-1.11],0.0917168026383707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,23999,120,1.00 [0.80-1.25],0.9767075379539908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,20560,100,1.24 [0.93-1.65],0.1391916460749557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,21226,105,1.24 [0.99-1.55],0.0639480790575348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,24795,121,1.54 [0.96-2.47],0.0752158816835473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,24670,121,1.68 [1.13-2.50],0.010417703519479
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,24693,122,1.63 [1.21-2.18],0.0012206912218574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,20704,98,1.33 [1.07-1.66],0.0091255110298923
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,24619,121,1.05 [0.81-1.34],0.7269938306367323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,21201,104,1.05 [0.83-1.32],0.6972019734662717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,20657,98,1.05 [0.79-1.40],0.7471439790336245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,21213,104,1.09 [0.91-1.32],0.3584047599863096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,24589,123,0.94 [0.78-1.12],0.4657652431042574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,20657,98,1.16 [0.77-1.73],0.4811824590611792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,24624,121,0.98 [0.82-1.17],0.8271812801120929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,21284,104,1.17 [0.85-1.59],0.3352012611754935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,20839,104,1.02 [0.87-1.20],0.8213749352975569
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,24421,122,1.28 [0.99-1.65],0.0557021623343735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",20726,100,0.98 [0.54-1.79],0.9599151633699388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',21260,104,1.40 [1.12-1.75],0.0035438777270228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,20651,100,1.24 [0.98-1.56],0.0763877690401066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,20839,104,1.06 [0.75-1.49],0.7527282871048585
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,21226,105,1.37 [0.98-1.93],0.0670674768625776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,21201,104,1.15 [0.93-1.41],0.1997024381229479
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,20726,100,1.82 [1.06-3.12],0.0285716225228986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,24589,123,1.12 [0.89-1.40],0.3240717561648519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],24036,119,1.12 [0.81-1.56],0.4907814232492049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",24565,119,1.39 [0.94-2.05],0.1016384524610148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,21324,106,0.95 [0.69-1.31],0.764649669517047
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,21284,104,1.05 [0.66-1.67],0.8374916648865142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,23987,116,2.33 [1.49-3.65],0.0002150376189982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,24686,121,1.14 [0.90-1.43],0.2760142486454982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,24561,123,1.02 [0.67-1.56],0.9159585609480556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,24561,123,1.02 [0.68-1.54],0.910187569599132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,20725,96,0.98 [0.65-1.49],0.9300004006505777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,21248,104,1.63 [0.81-3.28],0.1726512896104362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,20725,96,1.53 [0.74-3.15],0.2523520699259776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,21284,104,0.97 [0.52-1.83],0.9346840534284944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,21284,104,1.33 [1.04-1.70],0.0228758174032416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,24624,121,0.86 [0.70-1.07],0.1796525766063173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,24551,120,0.94 [0.52-1.70],0.8412702644920448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPART,Spartin,20839,104,1.10 [0.87-1.40],0.4167222485278083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,21317,104,1.98 [1.13-3.48],0.0167336660106789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,24565,119,1.51 [1.05-2.18],0.0270448155828627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,20839,104,1.38 [0.86-2.20],0.179477642629842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,24568,123,1.61 [1.29-2.02],3.3424021524230935e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,24565,119,0.62 [0.38-1.01],0.0549826487648048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,24795,121,1.06 [0.79-1.42],0.7197550300087469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,20651,100,0.84 [0.47-1.49],0.5478019906676406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,24478,119,2.27 [1.39-3.73],0.001112160065994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,24670,121,1.17 [0.79-1.74],0.4232483687963297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,21226,105,0.87 [0.77-0.97],0.0136055335566313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,24421,122,0.62 [0.33-1.17],0.1425327291094618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,24594,121,1.39 [0.86-2.26],0.1776312138651146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,24474,122,1.18 [0.74-1.90],0.4855840140500969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,24824,123,1.51 [1.07-2.14],0.0204195813969885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",20704,98,1.67 [1.23-2.27],0.0009575727869344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,20560,100,1.10 [0.82-1.47],0.5181620251488797
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,20915,101,1.09 [0.89-1.33],0.409830371415954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,21260,104,1.42 [1.10-1.84],0.0080092753077481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,24128,118,1.06 [0.89-1.26],0.5201497239524947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",20657,98,0.71 [0.37-1.38],0.3105745997380859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,21260,104,1.34 [0.89-2.00],0.1578267788419207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,24584,121,0.96 [0.84-1.10],0.568289373845771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,24459,123,1.05 [0.81-1.35],0.730713890694303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,24568,123,1.07 [0.89-1.28],0.4907219215929662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,21317,104,0.79 [0.47-1.35],0.3916514057744901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,23999,120,1.24 [1.00-1.53],0.0488248250450306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",20704,98,0.99 [0.58-1.70],0.969292793295857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,24561,123,1.03 [0.90-1.18],0.6722296251360027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,24632,120,0.81 [0.56-1.18],0.2765571783932345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,20560,100,0.79 [0.40-1.58],0.5102140550064455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,21226,105,1.16 [0.81-1.64],0.4199721359481055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,20839,104,1.14 [0.81-1.60],0.4447513175224805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",24459,123,1.25 [0.90-1.74],0.1768006281579937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24871,123,1.24 [0.72-2.12],0.4423149529719989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",20704,98,1.39 [1.07-1.80],0.0130192186528693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,21308,103,1.45 [0.76-2.76],0.2620548268170154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,21201,104,1.35 [0.87-2.10],0.177703332433235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,24374,122,1.18 [0.93-1.52],0.176849784226442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,20704,98,1.31 [1.04-1.67],0.0241597639707127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,24459,123,0.98 [0.87-1.10],0.6940731878685374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,20560,100,1.25 [0.99-1.58],0.0628946593146891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,24812,122,1.99 [1.45-2.72],2.1360698262624783e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,24527,119,1.87 [0.97-3.59],0.0596946607636427
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,20657,98,1.01 [0.78-1.31],0.9361042722310942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,24522,119,1.11 [0.87-1.41],0.4067074667028121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,24142,117,1.03 [0.83-1.29],0.7695895290949937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,23999,120,1.21 [0.94-1.56],0.1479336167116005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,24589,123,0.97 [0.81-1.16],0.7156151320713117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",20560,100,1.15 [0.97-1.35],0.1139086500051816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,23987,116,1.12 [0.85-1.46],0.4260940984910827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,20725,96,0.87 [0.52-1.47],0.6070228781698581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,21260,104,1.64 [1.20-2.24],0.0018279479176802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,24459,123,1.15 [0.91-1.45],0.2400289673774838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,20704,98,1.32 [0.93-1.87],0.1264912720867265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,23987,116,1.24 [1.01-1.52],0.0395224741891623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,20704,98,1.28 [0.87-1.89],0.2082753990723462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,24568,123,1.27 [0.94-1.71],0.113909393059268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,21284,104,1.05 [0.82-1.33],0.706376805083623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,23987,116,1.10 [0.77-1.57],0.6150313156508069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,21226,105,1.28 [0.84-1.93],0.2465813141866129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,23987,116,1.04 [0.85-1.27],0.7239485516377656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,24812,122,1.00 [0.88-1.13],0.948985194762275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,24568,123,1.16 [0.91-1.50],0.2334527004450962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,20704,98,1.04 [0.80-1.35],0.7806139881269164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,24812,122,0.88 [0.66-1.17],0.3730415966516602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",21284,104,1.22 [0.93-1.59],0.1547141735624329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,24142,117,0.78 [0.56-1.09],0.1484805627328146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,24565,119,1.26 [0.74-2.15],0.3931412948409248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,21201,104,1.59 [1.14-2.21],0.0060295282666976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,20728,103,1.45 [0.83-2.53],0.189185953479738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,20725,96,1.28 [0.98-1.67],0.0710513351322057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,21226,105,1.85 [1.36-2.52],8.442722055247216e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,20839,104,0.96 [0.69-1.33],0.7960229303155514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,20657,98,1.20 [0.90-1.62],0.2151709556763604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,21260,104,1.05 [0.65-1.71],0.8358607167983987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,21317,104,1.00 [0.77-1.29],0.9867035194625956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,20915,101,1.03 [0.86-1.23],0.7465657828194322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,24459,123,0.99 [0.87-1.14],0.9390146173108131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,21806,112,1.05 [0.58-1.88],0.8812459441909413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,21201,104,1.15 [0.72-1.83],0.552598951480012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,24459,123,1.43 [0.90-2.27],0.1255953433235261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,20560,100,1.08 [0.80-1.46],0.6158270058483405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,21238,103,1.56 [1.07-2.27],0.0194987709018341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,24128,118,1.11 [0.89-1.40],0.352539146933275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,20915,101,0.94 [0.67-1.33],0.745152534359645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,23999,120,1.11 [0.91-1.36],0.3199038833887174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",20725,96,1.07 [0.84-1.36],0.5689081290079154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",21201,104,1.26 [0.78-2.02],0.3452261953088793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,21260,104,1.26 [0.96-1.66],0.0978395015183145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,23999,120,1.28 [0.93-1.76],0.1305728075030733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,24459,123,1.01 [0.85-1.20],0.9038459108679467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,24568,123,1.14 [0.94-1.37],0.1794627569006688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,20839,104,1.11 [0.90-1.38],0.3398086248580637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,24421,122,1.03 [0.88-1.21],0.6771578651005158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,24421,122,1.09 [0.90-1.33],0.38645590162901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,23987,116,1.07 [0.88-1.30],0.4869768616127936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,20725,96,1.19 [0.84-1.68],0.3232340294942316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,24376,122,0.98 [0.83-1.15],0.7862343475074164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,24142,117,0.98 [0.79-1.21],0.8505224938482416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,20902,106,1.43 [0.94-2.16],0.0957600267042133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,24824,123,1.42 [0.86-2.36],0.1740592669018246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,21317,104,2.40 [1.77-3.24],1.5553435456183348e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,20915,101,0.95 [0.67-1.34],0.755686895779408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,21317,104,1.77 [0.95-3.28],0.071055323493687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,23999,120,1.05 [0.94-1.17],0.3923034894832022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",20725,96,1.38 [0.97-1.97],0.0750885636407943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,21201,104,1.37 [1.14-1.64],0.0006073328517225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,23999,120,1.24 [1.04-1.48],0.0181103389613926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,20651,100,1.20 [0.79-1.81],0.3864923562933271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,24624,121,0.91 [0.44-1.87],0.793691274928125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,20704,98,1.19 [0.64-2.24],0.5795152160212671
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,20886,101,0.98 [0.81-1.20],0.8788709888361487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,20725,96,0.91 [0.61-1.35],0.6257057624637461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,20915,101,0.75 [0.42-1.33],0.31933043927721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,21343,105,0.42 [0.18-0.98],0.0441542110103097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,20657,98,1.24 [0.94-1.63],0.1298411125608828
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,24453,118,1.10 [0.90-1.35],0.3363571784782415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,24635,121,1.25 [0.95-1.63],0.1067107602844466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,24534,120,1.35 [1.03-1.76],0.0288474562585992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,24471,119,1.15 [0.70-1.87],0.5856189600578248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,24541,121,1.25 [0.89-1.75],0.2030380299960131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,24651,120,1.56 [1.06-2.30],0.0236704083721129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,21201,104,0.95 [0.80-1.14],0.6069248393581301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,24568,123,1.06 [0.76-1.49],0.7198438340323299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,24830,124,1.36 [0.92-2.01],0.1232584635075241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,21201,104,0.79 [0.55-1.13],0.1954556830158207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,24394,119,0.68 [0.37-1.25],0.2143585495149221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,20704,98,1.24 [0.57-2.68],0.5832994342788046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,24624,121,2.07 [1.32-3.27],0.0016520814827345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,24871,123,1.48 [0.88-2.50],0.141430645639019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,24545,122,1.01 [0.81-1.24],0.9552325409149416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,21324,106,1.60 [0.78-3.32],0.2013271380393372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,20517,100,0.91 [0.71-1.15],0.4224479800661777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,24589,123,2.67 [1.56-4.56],0.0003275006836882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,24565,119,1.14 [0.74-1.76],0.5463929302128095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,24561,120,0.85 [0.59-1.21],0.3563182287181536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,24490,123,2.17 [1.40-3.37],0.0005089242519878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,24142,117,0.85 [0.55-1.31],0.4631846658443772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,20651,100,1.00 [0.85-1.19],0.963877490384242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,20553,97,1.36 [0.82-2.25],0.2266496407619393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,21160,104,1.07 [0.87-1.32],0.5175095251031215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,24812,122,2.01 [1.13-3.57],0.0177712233865478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,23876,116,0.99 [0.86-1.13],0.8731305865922772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,24871,123,1.49 [0.95-2.33],0.0800362186577545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23952,120,1.64 [1.25-2.15],0.000315281913383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20915,101,2.11 [1.74-2.56],3.0476934237209524e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,24632,120,1.37 [0.95-1.98],0.0874568819353501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,21317,104,1.18 [0.76-1.85],0.4648231360093271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,21260,104,1.05 [0.85-1.31],0.6297886067586351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,24271,119,1.59 [0.93-2.72],0.0867911779131203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,21317,104,1.47 [0.89-2.44],0.1319046947789188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,24670,121,1.00 [0.88-1.13],0.9717687375121468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,24565,119,0.90 [0.60-1.36],0.6235637382678134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,24515,123,3.72 [1.93-7.17],8.694972781371142e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,24624,121,1.06 [0.87-1.28],0.5598425334691575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,20657,98,0.98 [0.62-1.56],0.9300895720063704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",20915,101,1.70 [1.33-2.16],2.0252185752801573e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,20704,98,3.03 [1.84-4.99],1.3479814777712997e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,20915,101,1.16 [0.51-2.64],0.7170063656523781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,24879,125,1.12 [0.86-1.45],0.3955961595506353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,20704,98,0.73 [0.36-1.49],0.389182998275575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,20725,96,0.97 [0.67-1.41],0.880417542230127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,20915,101,0.87 [0.60-1.27],0.4676719860446874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,20651,100,1.07 [0.75-1.53],0.692351423112359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,20651,100,0.81 [0.54-1.21],0.297530210320157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,21226,105,1.03 [0.86-1.23],0.7807062084525624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,21201,104,0.95 [0.73-1.23],0.6788414061131702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,20726,100,0.86 [0.63-1.17],0.324864434203286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,21284,104,1.41 [1.02-1.94],0.0376325968687112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,20560,100,1.03 [0.65-1.65],0.8894109424653063
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,20657,98,1.01 [0.79-1.30],0.9314684532702026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,21212,104,1.33 [0.82-2.15],0.2473384791126862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,24459,123,0.80 [0.66-0.95],0.0129455478764631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,24297,122,1.45 [0.94-2.24],0.089418752940645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,24565,119,1.16 [0.94-1.43],0.1555431775572269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,24632,120,1.56 [1.12-2.16],0.0076614612793212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,24101,117,1.88 [1.58-2.24],1.8927281786019765e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,21226,105,1.51 [1.14-2.01],0.0042625671321482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,24128,118,1.05 [0.68-1.64],0.8147172446178195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,20839,104,1.01 [0.76-1.35],0.9407587682604552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24421,122,2.24 [1.62-3.10],9.818670592051712e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24421,122,1.43 [1.22-1.67],8.93648216648876e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,24605,123,1.00 [0.73-1.38],0.9933566327336264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24879,125,1.90 [1.28-2.82],0.0015068379687751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,24550,121,1.13 [0.66-1.93],0.6600988735993716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24624,121,1.38 [0.88-2.15],0.1554555977474243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24594,121,4.48 [3.38-5.93],9.9493893934312e-26
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,24128,118,2.86 [2.36-3.47],5.1529854384757466e-27
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24594,121,2.96 [1.84-4.75],7.76426915819651e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20839,104,3.47 [2.22-5.43],4.61614905078301e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24795,121,1.97 [1.22-3.18],0.0057524073943611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24565,119,3.04 [1.88-4.92],6.171339425367147e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24565,119,1.84 [1.50-2.25],4.192390638380098e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,24812,122,1.83 [1.03-3.25],0.0378486277744098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24830,124,6.19 [4.80-8.00],1.725176777037564e-44
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24421,122,1.57 [1.24-2.00],0.0002064016131328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24812,122,3.20 [2.55-4.01],8.025806543417056e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24421,122,3.95 [3.41-4.58],3.926517757148325e-74
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,24879,125,2.21 [1.21-4.03],0.0097276946842777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,24568,123,1.35 [1.05-1.75],0.0209599991836114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,24879,125,0.74 [0.43-1.27],0.2695815133815572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,24670,121,1.75 [0.97-3.16],0.063755636574876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,24821,123,1.45 [0.81-2.60],0.2110382718480764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,24421,122,0.92 [0.70-1.21],0.5597243630693518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,21308,103,3.04 [2.08-4.43],7.364991298453784e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,21260,104,1.15 [0.94-1.40],0.1871833266274508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,21308,103,0.97 [0.63-1.49],0.8964609685767594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",24142,117,1.03 [0.85-1.26],0.7546835800886946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,20915,101,1.15 [0.69-1.91],0.5997635849807363
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,24421,122,0.88 [0.60-1.29],0.5198871355393216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,24565,119,0.39 [0.21-0.71],0.0022439020383877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,21317,104,1.12 [0.89-1.42],0.3321724404638312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,21226,105,1.09 [0.93-1.28],0.2746084039238533
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",20560,100,0.98 [0.66-1.47],0.93649508661569
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,20704,98,1.25 [1.00-1.58],0.0537454591575648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,20726,100,1.39 [1.07-1.80],0.0129669795339863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,23987,116,1.11 [0.77-1.61],0.5758219872188546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,20704,98,1.24 [1.00-1.52],0.0456628680145921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,20383,102,1.43 [1.02-2.00],0.04043173228365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,24142,117,0.70 [0.37-1.34],0.2842461790240381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,20725,96,0.87 [0.49-1.55],0.6424260736988097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,20725,96,1.26 [0.82-1.93],0.2951740797759988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,20839,104,1.01 [0.85-1.21],0.8769718759801514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,21317,104,3.18 [1.71-5.91],0.0002486035567692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,20651,100,1.14 [0.76-1.71],0.526281344763385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,23987,116,1.08 [0.87-1.35],0.469946537513218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,24399,121,1.11 [0.80-1.56],0.5223282977777453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,20915,101,0.91 [0.70-1.18],0.4696276541641339
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,23999,120,1.39 [1.04-1.86],0.0282868376076203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,20651,100,1.44 [1.14-1.80],0.0017293482261056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,20560,100,0.88 [0.63-1.24],0.469430634266502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,24839,125,1.09 [0.80-1.47],0.5880449309726128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,21284,104,1.06 [0.65-1.72],0.8218043751965594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,20704,98,0.94 [0.46-1.93],0.8672413543162579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,24128,118,0.95 [0.73-1.23],0.6763733290773646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,24568,123,1.16 [0.93-1.44],0.1810551860076565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",20704,98,1.37 [0.94-1.98],0.0982250429106198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,20651,100,1.02 [0.68-1.51],0.938902774585251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,20915,101,1.00 [0.79-1.26],0.9897009567452916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,21308,103,0.84 [0.66-1.06],0.1478900412851596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,24550,121,1.60 [1.20-2.14],0.0012376628589957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,21324,106,0.94 [0.66-1.33],0.7143382436798584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,24565,119,1.45 [0.90-2.34],0.1316939087533911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,24795,121,1.11 [0.87-1.42],0.4158555025182907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,24568,123,0.85 [0.70-1.05],0.125730129932926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,20869,101,1.24 [0.95-1.60],0.1086745269353088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,21226,105,1.13 [0.95-1.34],0.1549407303994192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,20560,100,1.11 [0.83-1.50],0.4831102680394595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,20725,96,0.83 [0.63-1.10],0.1975224843237229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,24568,123,1.04 [0.87-1.25],0.6476773804227743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,21201,104,1.15 [0.93-1.43],0.1949190248290816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,20651,100,1.12 [0.79-1.58],0.533052347061917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,20704,98,1.34 [1.13-1.59],0.0006586847995078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,21284,104,1.15 [0.88-1.49],0.3037978665583147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,24589,123,0.98 [0.79-1.21],0.858005774810496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,24142,117,1.14 [0.90-1.45],0.2677593766875858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,20651,100,1.31 [0.82-2.07],0.25816656660118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,24142,117,1.11 [0.78-1.58],0.5740625160989022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,20651,100,0.80 [0.51-1.24],0.3162743134736422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,20657,98,0.99 [0.81-1.22],0.934883066991148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,21226,105,1.02 [0.85-1.24],0.8066857386274188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,20704,98,0.98 [0.60-1.58],0.9242058066047978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,23968,120,1.08 [0.88-1.34],0.4595671276211723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,20725,96,1.20 [0.83-1.73],0.3407511650303236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTN,Titin,20651,100,1.17 [0.92-1.48],0.1979771008114277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,21108,102,0.65 [0.31-1.36],0.2498511654429911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,20657,98,1.35 [0.70-2.60],0.3723981052625297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,21308,103,1.08 [0.87-1.34],0.509044655691522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,20915,101,1.13 [0.90-1.41],0.2900196554396883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,24421,122,1.12 [0.93-1.34],0.2295691517706043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,20968,105,1.52 [1.08-2.13],0.0164306075332055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,24624,121,1.35 [0.76-2.39],0.3076427562184436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,24812,122,1.22 [0.98-1.52],0.0816442363652526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,21260,104,1.14 [0.82-1.59],0.4460687120002308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,20620,98,1.09 [0.91-1.30],0.3650823335575114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",24565,119,1.13 [0.81-1.59],0.4729595513113405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,24438,122,1.11 [0.88-1.40],0.3852388093885056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,24589,123,1.08 [0.61-1.89],0.7990101930827596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",20704,98,1.20 [0.87-1.65],0.2699883169517607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,24459,123,1.35 [0.86-2.13],0.1931655758255603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,21201,104,1.54 [0.87-2.71],0.1368267001580753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,21317,104,1.58 [1.19-2.10],0.0015147058776018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,20704,98,1.36 [1.06-1.75],0.0169674513975335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,20651,100,0.73 [0.45-1.19],0.2056118445508562
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,20839,104,1.13 [0.87-1.48],0.3550230079744711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,21226,105,1.02 [0.90-1.17],0.7378639030224492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,20651,100,1.11 [0.95-1.30],0.1994020226540317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,20651,100,1.29 [0.82-2.02],0.2649580486142125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,24421,122,2.10 [1.43-3.08],0.0001587723637438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,24785,123,0.92 [0.69-1.24],0.596946656445746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,20704,98,1.40 [0.73-2.68],0.3059344460640977
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,20560,100,1.20 [0.88-1.64],0.2587991113310248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,21201,104,0.91 [0.53-1.58],0.7453793516254699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,21317,104,0.98 [0.80-1.19],0.8129989325896247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,20657,98,1.06 [0.71-1.57],0.7760951645196028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,20879,101,1.00 [0.70-1.43],0.9803792922447524
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,20839,104,1.10 [0.84-1.44],0.4946041376232065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,20725,96,1.24 [0.97-1.58],0.0882144810118561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,24459,123,1.03 [0.86-1.23],0.7305751361167017
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,21201,104,1.24 [0.96-1.59],0.0939667638282021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,21260,104,1.46 [1.01-2.10],0.0451485337640751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,20651,100,1.09 [0.89-1.34],0.4122898790757406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,24142,117,1.05 [0.89-1.25],0.5538218604967438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,23987,116,1.05 [0.77-1.44],0.7469443217467944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,24142,117,1.31 [1.03-1.67],0.0268896618175255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,20704,98,1.06 [0.86-1.32],0.5790891346203517
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,24568,123,0.97 [0.80-1.17],0.7394795606912818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,24163,119,0.78 [0.43-1.41],0.4096814173390335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,21324,106,1.11 [0.87-1.42],0.4053068160216625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,24459,123,1.33 [0.60-2.91],0.4826918247180917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,20657,98,1.10 [0.91-1.33],0.3240020450722604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,24603,120,4.84 [3.02-7.74],4.9639831457243246e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,24812,122,1.15 [0.68-1.96],0.6052976493808786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,20560,100,0.88 [0.68-1.14],0.3277186190198062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,24799,124,1.32 [1.02-1.71],0.0321750253181488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,20704,98,0.98 [0.50-1.92],0.956596337347792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,24624,121,0.83 [0.62-1.10],0.1873634408040138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,24839,125,1.00 [0.64-1.55],0.9935277395418272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,21284,104,0.98 [0.52-1.84],0.9552527810930264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,24142,117,1.02 [0.89-1.18],0.7349250881254604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,20726,100,1.39 [0.75-2.59],0.2968471770293347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,21317,104,1.05 [0.64-1.73],0.8534942679046753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,24459,123,1.35 [1.04-1.74],0.0227296987677641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,21324,106,0.83 [0.65-1.06],0.1320624127376826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,24459,123,1.07 [0.76-1.50],0.716224480814944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,20915,101,1.30 [1.00-1.67],0.0467964342935271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,24459,123,1.14 [0.94-1.39],0.1775773420067306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,21201,104,1.08 [0.89-1.31],0.414359619257086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,24459,123,0.97 [0.79-1.19],0.7420647134039755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,21201,104,1.26 [0.83-1.93],0.2814849464244086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,20651,100,0.81 [0.44-1.47],0.4869358400317244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,21201,104,1.54 [1.16-2.05],0.0030176515122487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,24527,119,2.29 [1.59-3.31],9.779808131651223e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,24553,122,1.04 [0.81-1.34],0.7449029907660936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,21260,104,0.80 [0.49-1.33],0.3968481921856673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,23999,120,0.99 [0.71-1.38],0.943187910422775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,20915,101,0.94 [0.58-1.51],0.7937859956118046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,24142,117,0.96 [0.71-1.28],0.7617190983858896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,24812,122,0.96 [0.77-1.20],0.7031258253360781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,23987,116,1.28 [0.78-2.09],0.3303332663859499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20839,104,1.18 [0.87-1.60],0.2840372386125799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,24763,121,1.02 [0.70-1.48],0.9232051904881032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,20560,100,1.10 [0.90-1.35],0.3616014706665087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,24333,122,1.67 [1.11-2.51],0.0137673732754374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,21284,104,1.17 [0.84-1.63],0.3494146804172935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,24871,123,1.17 [0.95-1.45],0.1429251536941621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",24565,119,2.08 [1.37-3.16],0.000598818759871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,24128,118,1.26 [1.02-1.57],0.0355453471395006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,24142,117,1.06 [0.89-1.26],0.5258065892625993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,23999,120,1.15 [0.95-1.40],0.1393390240458649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,21260,104,1.26 [1.01-1.57],0.0369607602210024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,20704,98,1.02 [0.75-1.40],0.8926281919631239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,21201,104,1.15 [0.73-1.83],0.5428283819638364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,20785,103,1.29 [0.98-1.70],0.0732648986677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,24753,121,1.04 [0.81-1.33],0.7616772069912274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,23282,114,2.54 [1.80-3.59],1.3665207649454898e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",24344,122,0.87 [0.58-1.30],0.5002424139414701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",24594,121,0.89 [0.56-1.43],0.6354013650767198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,24795,121,1.03 [0.64-1.65],0.9042801281335549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,24128,118,1.97 [1.26-3.09],0.0030080873321488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,24421,122,1.35 [1.02-1.80],0.0373443356548144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,24795,121,1.38 [1.10-1.72],0.0048503937311878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,24743,123,1.34 [0.80-2.25],0.2695323931915895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,20704,98,1.23 [0.89-1.69],0.2048110931193167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,24624,121,0.94 [0.81-1.10],0.4441038675789315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,23999,120,1.35 [0.90-2.01],0.1442811587618225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,21260,104,1.77 [0.93-3.37],0.0824862713475667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",21226,105,1.07 [0.94-1.21],0.32762607762226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,24459,123,1.02 [0.89-1.17],0.8166996975616725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,21201,104,1.24 [0.72-2.14],0.432078982145175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,20651,100,1.26 [0.93-1.70],0.1310505533878793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,24128,118,0.99 [0.82-1.20],0.9147739670798763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,20839,104,1.11 [0.86-1.42],0.420624055373717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,20704,98,1.99 [1.10-3.58],0.0225087333530649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,20704,98,1.97 [1.55-2.51],3.9451669395678576e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,23987,116,1.10 [0.88-1.37],0.4210171669404802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,24142,117,1.88 [1.48-2.39],2.667157798006988e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,20651,100,1.28 [1.01-1.63],0.0415433385101616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,21226,105,0.99 [0.81-1.21],0.9160524656005572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,21260,104,1.74 [1.33-2.28],5.126224276538162e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,20704,98,1.25 [0.82-1.91],0.3048918611164884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,20915,101,1.22 [0.95-1.57],0.1226212452561824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,21201,104,1.11 [0.90-1.37],0.3231699857308172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,21226,105,1.36 [1.06-1.74],0.0139411005130962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,21201,104,0.81 [0.56-1.17],0.2687802085713164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,20726,100,0.99 [0.92-1.07],0.8662518783088885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,20560,100,0.83 [0.43-1.60],0.5751955404159368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,20657,98,1.04 [0.85-1.26],0.728434101798848
